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ABSTRACT 
Yousef M. Aljawarneh, Ph.D.(c), M.C.B., R.N. 
Associations between Physical Activity, Health-Related Quality of Life, Regimen 
Adherence, and Glycemic Control in Jordanian Adolescents with Type 1 Diabetes 
May, 2018 
 
Background: Adolescents with Type 1 Diabetes (T1D) display a greater than two-fold 
higher risk of developing diabetes-related complications compared with the their healthy 
peers and the risk increases markedly as glycated hemoglobin (HbA1c) increases. The 
majority of the findings on the associated factors with improved glycemic control are 
geared toward Western population with a clear lack of studies on Middle Eastern 
populations. Purpose: This study aimed to examine the effect of Physical Activity (PA), 
Health-Related Quality of Life (HRQoL), and regimen adherence on glycemic control in 
Jordanian adolescents with T1D. Methods: The study utilized a cross-sectional design. 
Jordanian adolescents (aged 12-18) with T1D (n=74) were recruited. Self-reported 
measures were used including the Pediatric Quality of Life-Diabetes Module, the 
International Physical Activity Questionnaire, and the Summary of Diabetes Self-Care 
Activities. HbA1c values were obtained from the medical records. Correlation analyses 
were conducted using Pearson’s and Spearman’s correlation tests. Multiple regression 
analyses were conducted to determine if HRQoL, PA, and regimen adherence predict 
glycemic control. Results: Only 14.8% of the participants demonstrated good glycemic 
control (HbA1c ≤ 7.5%). Participants with poor control had a statistically significant 
lower mean PA of MET-minutes/week (3531.9 ± 1356.75 vs. 1619.81 ± 1481.95, p < 
.001) compared to those with good control. The total sample was found to demonstrate 
 
 
v 
 
low HRQoL (47.70 ± 10.32).  Participants were within the acceptable range of PA 
(1885.38 ±1601.13) MET-minutes/week. HbA1c significantly inversely correlated with 
PA (r = -.328, p = .010) and regimen adherence (r = -.299, p = .018). Regimen adherence 
and PA significantly predicted HbA1c in the unadjusted regression model (β = -.367, p < 
.01; β = -.409, p < .01) and after adjustment for age and disease duration (β = -.360, p < 
.01; β = -.475, p < .01). In the interaction model, the interaction between PA and regimen 
adherence was statistically significant (β = -.304, p < .05). Conclusion: Better glycemic 
control was significantly predicted by higher PA and regimen adherence levels. There 
was no significant association between glycemic control and HRQoL. Further research is 
needed to provide more information on psychosocial and cultural factors that impact 
glycemic control and quality of life in this population 
Keywords: adolescents, glycemic control, physical activity, quality of life, 
regimen adherence, type 1 diabetes. 
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Summary  
The dissertation study entitled “Associations between Physical Activity, Health-
Related Quality of Life, Regimen Adherence, and Glycemic Control in Jordanian 
Adolescents with Type 1 Diabetes” is presented in this book. The purpose of the study 
was to examine the associations between PA, HRQoL, regimen adherence, and glycemic 
control in Jordanian adolescents (aged 12-18) with T1D and to determine if HRQoL, PA, 
and regimen adherence predict glycemic control while adjusting for age and disease 
duration in this population. This book includes the proposal of the study, the final 
manuscript describing the background, the purpose statement, the statement of the 
problem, the specific aims and hypotheses, the conceptual framework, methods, 
statistical analyses, results, discussion, conclusions, and recommendations. The book also 
includes a manuscript submitted for publication in the BMC Health Services Research 
Journal and entitled “Arabic Translation and Psychometric Evaluation of the Adherence 
in Diabetes Questionnaire in Jordanian Adolescents with Type 1 Diabetes: Proposal and 
Protocol”. The appendixes contain the Institutional Review Board (IRB) approvals, 
consent forms, study flyers, instruments used for data collection, and the detailed study 
protocol. The final section of the dissertation is the curriculum vitae of the researcher.   
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ABSTRACT 
Background: Poor glycemic control in adolescents with Type 1 Diabetes (T1D) 
increases the risk for microvascular and macrovascular complications. Several predictors 
have been found to be significantly correlated with better glycemic control; however, the 
findings are geared to a Western population with a clear lack of studies on Middle 
Eastern populations. This study aims to assess the correlation of glycemic control and 
adherence, health-related quality of life (HRQoL), and physical activity (PA) in 
Jordanian adolescents with T1D. Research Design and Methods: This is a cross-
sectional study. A convenience sample of 74 T1D adolescents (aged 12-18) will be 
recruited from King Abdullah University Hospital in Jordan. Clinical and personal data 
will be collected. Self-reported measures will be used; the Pediatric Quality of Life-
Diabetes Module for HRQoL, the International Physical Activity Questionnaire for PA, 
and the Summary of Diabetes Self-Care Activities for adherence. Data on the glycemic 
control will be obtained from the medical records. Data Analysis: Data will be 
summarized according to each instrument’s scoring criteria. Descriptive statistics will be 
used to calculate percentages and counts for categorical variables, and means and 
standard deviations for continuous variables. The Pearson correlation coefficient will be 
computed to examine the correlations between the variables. The generalized linear 
model test will be used to examine the predictability of PA, HRQoL, and adherence on 
glycemic control. Future Implication: Better understanding of how PA, HRQoL, and 
adherence impact glycemic control will enable researchers and clinicians to design 
interventions that promote these factors and positively improving clinical outcomes in 
this population. 
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Specific Aims 
Traditionally, the management of Type 1 Diabetes (T1D) has relied heavily on the 
pharmacological treatment components to minimize and prevent medical complications. 
However, the medical approach has changed to emphasize the importance of including all 
health dimensions including social, psychological, and emotional components of patients’ 
life. Controlling blood glucose levels and improving glycemic control in adolescents with 
T1D substantially decreases the risk of macro and microvascular complications (Demirel, 
Tepe, Kara, & Esen, 2013). Therefore, the guidelines of T1D treatment intensify 
controlled glycemic status (Cheng et al., 2013; American Diabetes Association [ADA], 
2014), which is  measured by the glycohemoglobin (HbA1c) level, a measure of the 
average level of blood sugar over the past 2 to 3 months (Hanas & John, 2010). Despite 
the fact that the recommended level of less than 7.5% is generally associated with 
decreased risk of diabetes complications compared with higher levels, few of the 
adolescents with T1D achieved this target (Livingstone et al., 2012). Patient adherence is 
important for effective outcomes of any medical treatment. Failure to adhere to diabetes 
treatment regimens can worsen glycemic control that can lead to negative clinical 
outcomes (Borus & Laffel, 2010). The presence of a chronic condition such as T1D 
during adolescence leads to significant stress and anxiety that is associated with risk for 
behavioral and emotional problems and hindrance with adherence to therapeutic regimens 
(Compas, Jaser, Dunn, & Rodriguez, 2012). 
Quality of life is considered as an important component of chronic disease 
treatment. Also, more emphasis has been given to assessing, monitoring, and studying the 
health-related quality of life (HRQoL) of adolescents with T1D (Abdul-Rasoul, AlOtaibi, 
Abdulla, Rahme, & AlShawaf, 2013). Moreover, adolescents with T1D and their parents 
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congruously demonstrated lower HRQoL scores compared with healthy people of the 
same age and gender (Özyazıcıoğlu, Avdal, & Sağlam, 2017). 
Physical activity (PA) is considered an essential component of the management of 
T1D for decades. Several studies found an inverse correlation between PA and HbA1c 
levels (Herbst et al., 2007; Herbst, Bachran, Kapellen, & Holl, 2006). In contrast, several 
meta-analyses reported contradictory results, while Quirk and colleagues (2014) 
suggested an improvement in the glycemic status of physically active adolescents with 
T1D, Kennedy and colleagues (2013) did not find an association between glycemic 
control and PA in adolescents with T1D. 
The majority of research on T1D has been conducted in North America and 
Europe with very little research conducted in the Middle East. Given the differences in 
health care delivery systems, cultural components, family structure, and religion 
orientations in different countries, the findings of these existing studies may not be 
generalizable to Middle Eastern adolescents. Therefore, the present study seeks to 
address this gap by examining the effect of PA, HRQoL, and adherence on glycemic 
control in Jordanian adolescents (aged 12-18) with T1D. The present study represents the 
starter of a long-term research trajectory aimed on understanding the various individual, 
psychosocial, and physiological factors that impact the glycemic control in this 
population. Further research in this population will hopefully provide more information 
and understanding of the factors that facilitate disease management and develop 
interventions that can improve medical and psychosocial outcomes of T1D. Study aims 
and hypotheses are as follows: 
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Aim 1: Examine the association between PA and glycemic control in Jordanian 
adolescents with T1D. Hypothesis 1.1: Adolescents having high PA levels would have a 
glycemic control ≤ 7.5% as measured by HbA1c, independent of age and disease 
duration. Aim 2: Evaluate HRQoL of Jordanian adolescents with T1D and examine 
gender and its association with glycemic control. Hypothesis 2.1: There are significant 
gender differences in adolescent HRQoL (specifically, girls have poorer self-rated 
HRQoL than boys), independent of age and disease duration. Hypothesis 2.2: 
Adolescents having low HRQoL scores would exhibit high levels of glycemic control 
(HbA1c ≥ 9%), independent of age and disease duration. Aim 3: Examine the association 
between regimen adherence and glycemic control in Jordanian adolescents with T1D. 
Hypothesis 3.1: Adolescents with high adherence scores would have a glycemic control ≤ 
7.5% as measured by HbA1c, independent of age and disease duration. Aim 4: Examine 
the interaction between PA, HRQoL, and adherence in the prediction of glycemic control 
in Jordanian adolescents with T1D.  Hypothesis 4.1: The HRQoL will interact with 
adherence in the prediction of glycemic control with higher scores in both variables 
predict a glycemic control of ≤ 7.5% as measured by HbA1c. Hypothesis 4.2: The 
HRQoL will interact with PA in the prediction of glycemic control with higher scores in 
both variables predict a glycemic control of ≤ 7.5% as measured by HbA1c. Hypothesis 
4.3: There will be no interaction between PA and adherence in the prediction of glycemic 
control in Jordanian adolescents with T1D. 
Research Strategy 
Significance 
Type 1 diabetes is an autoimmune disease affecting children and adolescents and 
considered as the second most common chronic condition in this population. About 1.25 
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million Americans are living with T1D including about 200,000 youth (less than 20 years 
old) (Centers for Disease Control and Prevention, 2014). Prevalence and incidence of 
T1D vary between countries (Maahs, West, Lawrence, & Mayer-Davis, 2010). In the 
Arab world, there is clear epidemiological evidence that the incidence of T1D is high 
(Elhadd, Al-Amoudi, & Alzahrani, 2007), particularly in the Gulf region with large 
variations in the incidence, ranging from low in Oman (2.54/100,000) (Soliman, al-Salmi, 
& Asfour, 1996) to high in Saudi Arabia (29/100,000) (Habeb et al., 2011). Several 
factors play a major role in these variations such as culture, vast gap in socioeconomic 
status, wide geographical range, and high rates of first-cousin marriage and endogamy 
which created several inbreeding communities with increased homozygosity of both the 
human leukocyte antigen (HLA) haplotypes and non-HLA genes associated with 
susceptibility to T1D among Arabs (Zayed, 2016). 
 Relatively, Jordan has a low incidence of T1D, but it is increasing (Ajlouni, 
Khader, Batieha, & El-Khateeb, 2008).The majority of the populations of Jordan are of 
Arab origin. Two minority groups immigrated to Jordan 140 years ago; Circassian and 
Chechen with a total population of 80,000 and 30,000 respectively. A study conducted in 
2012 by Dajani et al, found that the prevalence of T1D among Circassians and Chechens 
was higher than in the Jordanian population. The study concluded that factors such as 
genetic predisposition, lifestyle, and unhealthy dietary pattern were related to these 
differences. 
Adolescence is a theoretical construct that is dynamically evolved through 
biological, psychological, social, cultural and transitory perspectives (Curtis, 2015). This 
developmental period is classically known as the time between the onset of puberty and 
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beginning of social independence (Steinberg, 2014). Adolescence is broadly defined 
using the chronological definition that includes the age of 10 to 19; however, the range 
may include a wider span of 9 to 26 years depending on the source (Curtis, 2015). In 
contrast, the World Health Organization believes that the chronological definition of 
adolescence is only one aspect that describes this period of development and a more 
functional definition based on the biopsychosocial characteristics should be considered 
(WHO, 2003). 
While the appreciation for the developmental variability is essential when 
studying adolescence, confusion may arise in the construction of adolescent research due 
to inconsistencies in the inclusion criteria. Therefore, the operational definition of 
adolescence chronology of 12 to 18 years will be employed in this study. Certainly, a 
great developmental variance occurs between the ages of 12 through 18 years and thus 
adolescents can be divided into sub-stages; early adolescence as approximately 12 to 14 
years, and late adolescence as approximately 15 to 18 years (Irwin, Burg & Cart, 2002). 
Early adolescence is broadly described by the onset of physical and sexual maturation 
accompanied with early cognitive development. These changes can be a source of anxiety 
and excitation as their body is undergoing the transformation (Radzik, Sherer, & 
Neinstein, 2002). At this stage, boys and girls start making adjustments to behaviors to fit 
with perceived norms (Steinberg, 2014). In late adolescence, the brain continues to 
develop with increased capacity for reflective and analytical thoughts. Also, adolescents 
at this stage develop the ability to evaluate risks and make reasonable decisions, seek 
greater autonomy, and being independence from adult guardians (Garrison & Felice, 
2009). In respect to T1D, these age-related differences may contribute to disagreements 
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between parents and their adolescents with T1D regarding diabetes care responsibilities 
(Helgeson, Becker, Escobar, & Siminerio, 2012; Nordfeldt et al., 2013). The presence of 
diabetes in adolescence can be an additional source of stress and potentially exposes 
teens to negative experiences that can influence their social, emotional, and 
developmental aspects of their lives (De Wit et al., 2007). 
Adherence is a concept widely used to reflect a patient’s ability to follow 
healthcare advice and achieve effective clinical outcomes. World Health Organization 
(WHO) defined adherence as “the extent to which a person’s behavior (taking 
medications, following a recommended diet and/or executing lifestyle changes) 
corresponds with the agreed recommendations of health professionals” (2003, p.3).As 
recognized in Healthy People 2020 goals, improving glycemic control among persons 
with diabetes requires an increased focus on non-adherence risk factors and puts more 
emphasis on behavioral and psychosocial components of diabetes self-management 
(Office of Disease Prevention and Health Promotion, 2016). Patients with diabetes are 
recommended to adhere to many self-management behaviors to prevent diabetes-
associated complications (American Association of Diabetes Educators, 2014). In case of 
T1D, this is considered a challenge where patients must meet the demands of lifelong 
disease management (ADA, 2014). 
Poor adherence to diabetic therapeutic regimens seems to result from a 
multifactor combination of factors that may derail health outcomes (Cox & Hunt, 2015). 
Moreover, adolescents with T1D are less adherent to blood glucose monitoring, insulin 
therapy, diet, and PA compared with children (Patton, 2011). The measurement of 
diabetes regimen adherence is typically accomplished by calculating the number of times 
10 
 
 
 
the patient takes insulin, checks blood glucose levels, regulates carbohydrates intake, and 
performs physical activities as recommended (Garcia-Pérez, Álvarez, Dilla, Gil-Guillén 
& Orozco-Beltrán, 2013). Therefore, adherence to such complex treatment regimens 
challenges even the most competent and motivated adolescent (Borus & Laffel, 2010). 
Health-related quality of life is a multidimensional concept that describes the 
social, physical, mental, and emotional well-being and reflects how the effects and 
treatment of diseases are perceived by the patient (Clarke & Eiser, 2004). The HRQoL 
was found to affect several life domains in adolescents with T1D including physical and 
social aspects, educational performance, and emotional well-being (Varni, Burwinkle, 
Jacobs, Gottschalk, Kaufman, & Jones, 2003). Studying HRQoL and associated factors in 
adolescents with T1D can provide more insight into their physical, psychological, and 
social needs which in turn would help in designing the appropriate regimen that fits with 
the expected clinical outcomes (Huang et al., 2004). 
Compared to glycemic control, studies have shown that enhancing the HRQoL of 
adolescents with T1D is considered as a paramount factor in preventing diabetes 
complications and disease morbidities (Da Costa & Vieira, 2015). The literature indicates 
that the majority of studies on HRQoL in adolescents with T1D had been conducted in 
Australia and Western countries, and very few studies had been conducted in the Arab 
countries (Al-Hayek et al., 2014; Abdul-Rasoul et al., 2013). In Jordan, only one study 
has been conducted and reported low levels of HRQoL in Jordanian adolescents with 
T1D (Al-Akour, Khader, & Shatnawi 2010). While there is a clear difference in the 
cultural components, family structure, lifestyles, and healthcare systems between 
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different societies, it is important to study to which extent HRQoL may influence the 
management and clinical outcomes of T1D in such communities.  
Physical activity is an important aspect of T1D management. According to ADA 
(2014) guidelines, children with T1D or pre-diabetes are recommended to perform at 
least one hour of regular PA on daily basis. Regular PA has been found to increase 
cardiovascular fitness, decrease body fat composition, decrease daily insulin doses, and 
improve the quality of life in patients with T1D (Chimen, Kennedy, Nirantharakumar, 
Pang, Andrews, & Narendran, 2012). Several observational studies found that lower 
prevalence, incidence, severity, and complications of T1D were associated with higher 
levels of PA in adolescents with T1D (Tielemans et al., 2013; Kennedy et al., 2013). In 
contrast, there is a clear lack of evidence on the effect of PA on the glycemic control in 
adolescents with T1D (Chimen et al., 2013; Kennedy et al., 2013). Some studies reported 
improvement in glycemic control with increased levels of daily PA in adolescents with 
T1D (Herbst, Bachran, Kapellen, & Holl, 2006), but others have not found an association 
(Aman et al., 2009; Galler, Lindau, Ernert, Thalemann, & Raile, 2011). Several studies 
that assessed PA in adolescents revealed that PA levels are sub-optimal (Aman et al., 
2009; Kennedy et al., 2013; Overby et al., 2009) because of a fear of hypoglycemia or 
low levels of cardiorespiratory fitness (Wild et al., 2007). Therefore, it is important to 
examine the effect of PA on glycemic control and understand how cultural components 
may affect the rate of PA in Jordanian adolescents with T1D. 
Finally, this study will provide an increased understanding of the influence of PA, 
HRQoL, and adherence on glycemic control in adolescents with T1D. Since cultural 
differences in family structure, lifestyle, food consumption, and physical and leisure 
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activities vary substantially between adolescents from different countries; studying 
Jordanian population will provide needed insight on how these factors could explain and 
influence on metabolic outcomes differently that, in turn, will enable researchers and 
clinicians to provide culturally-tailored interventions that promote and enhance these 
factors and positively improving clinical outcomes of this population. 
Conceptual Framework 
A conceptual framework for glycemic control in adolescents with T1D was 
developed by the primary researcher to serve as the theoretical model for this study 
(Figure 1). The framework illustrates glycemic control as an outcome of the positive 
contribution of three main variables: physical activity, health-related quality of life, and 
regimen adherence. Within this framework, the three predictors are interrelated and 
directly influence the glycemic status of adolescents with T1D. When considering 
variables that may influence adolescents’ glycemic control, it is key to acknowledge the 
role of factors within adolescent’s context that may influence the glycemic status such as 
age, gender, disease duration (length of time since diagnosis), and diabetes-related co-
morbidities. These factors can directly or indirectly influence levels of physical activity 
the adolescents perform, their quality of life, and their ability to adhere to their 
therapeutic regimens. 
Innovation 
Poor glycemic control in adolescents with T1D can affect growth and expose 
adolescents to frequent episodes of hypoglycemia which can adversely impair 
neurological development. Furthermore, adolescents with T1D are generally more 
susceptible to the rapid development of diabetic ketoacidosis (DKA) than adults due to 
higher sensitivity to lack of insulin (Usher-Smith, Thompson, Ercole, & Walter, 2012). 
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Even in developed countries, there is clear epidemiological evidence that the mortality 
rates from DKA are significantly high in children and adolescents with T1D (Wolfsdorf 
et al., 2014). Given that T1D requires collaboration between the adolescent, the family, 
and healthcare providers; promoting PA, HRQoL, and adherence are likely to have a 
positive influence on glycemic control and clinical outcomes (Jaser et al., 2012). There is 
clear lack of studies on T1D in the Middle East (Memon et al., 2014). In Jordan, there are 
none published, as of August 2017, clinical studies that investigated the influence of 
HRQoL, PA, and adherence on glycemic control and subsequently the clinical outcomes 
in adolescents with T1D. Consequently, it becomes important to realize how controlled 
glycemic status of T1D patients influences quality of life, social competence, physical 
and cognitive development. Therefore, this study seeks to provide a better understanding 
of how PA, HRQoL, and regimen adherence impact glycemic control in this culturally 
unified population. 
Approach 
Research Design and Setting. The study will utilize a cross-sectional design to 
investigate the associations between PA, HRQoL, regimen adherence, and glycemic 
control. The participants will be Jordanian adolescents with T1D visiting the pediatric 
endocrinology clinic at King Abdullah University Hospital, a referral tertiary hospital 
located at north of Jordan. The study will commence when IRB approval is obtained and 
last until sample recruitment is complete. 
Population, Sample and Sampling Procedures. The study sample will be 
Jordanian adolescents with T1D. Inclusion criteria for study participation are: (a) 
diagnosis of T1D >12 months; (b) age 12-18 years (c) have been a patient in the clinic 
over the course of at least one year and have at least 3 measurements of HbA1c; (d) free 
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of major mental health diagnosis; (e) able to read, write, and speak Arabic; and (f) willing 
to participate in the study and have parental consent. Participants will be excluded if they 
have a medical condition that interferes with physical activity recommendations. For a 
fixed-model multiple linear regression with three predictors, assuming an R2 deviation 
from zero, a total sample size of 59 is required to achieve 80% power with a medium 
effect size of F2 = 0.20 given the two-sided type I error of 5%. Given that a maximum of 
missing or incomplete data could be approximately 25%, the enrollment goal of the study 
is estimated to recruit 74 total subjects. A non-probability convenience sampling method 
will be used. Flyers for the study site will be posted to announce the study. The name and 
address of the investigator, a brief description of the study, the purpose of the study, 
method and duration of data collection, the contact person for further information, and a 
summary of inclusion criteria will be included. 
Instruments 
Demographic and medical history questionnaire. A structured questionnaire 
developed for the purpose of the study will be utilized to collect data on participants’ age, 
gender, education level, parents’ education, parents’ employment, disease duration, body 
mass index, diabetes-related co-morbidities, and insulin regimen modality. 
Health-Related Quality of Life. Health-related quality of life will be measured 
using the Arabic version of The Pediatric Quality of Life Inventory 3.0 Diabetes Module 
(PedsQL-MD), a culturally adapted version from the original instrument; The Pediatric 
Quality of Life Inventory (PedsQL). The PedsQL is a modeled-designed instrument used 
to measure HRQoL in children and adolescents aged 12-18 years (Varni, Burwinkle, 
Jacobs, Gottschalk, Kaufman & Jones, 2003). The PedsQL-MD Module was designed to 
measure diabetes-specific HRQoL in children and adolescents with T1D aged 12-18years 
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(Varni et al., 2003). The PedsQL-MD consists of 28 items with five subscales: Diabetes 
(11 items), Treatment I (4 items), Treatment II (7 items), Worry (3 items), and 
Communication (3 items). Respondents rate their responses on a 5-point Likert scale (0 = 
never a problem, 4 = almost always a problem). Data analysis will be performed 
following the “Scaling and Scoring of the Pediatric Quality of Life Inventory™ PedsQL” 
(Varni, 2014). To compute each score, all items will be reversed and linearly transformed 
to a 0-100 scale. The total score will be calculated by summing of all items divided by the 
number of answered items on the total scale. To account for missing data, the scale score 
will not be computed if more than 50% of the items are missing. The instrument has been 
previously used in Arabic-speaking children with T1D and has demonstrated satisfactory 
internal consistency reliability (Cronbach’s alpha ˃ 0.70) (Abdul-Rasoul et al., 2012). 
The required time to complete the instrument was evaluated and found to be 5-7 minutes 
with minimal missing responses indicating its feasibility. 
Physical Activity. Physical activity will be measured using the official Arabic 
short-version of The International Physical Activity Questionnaire for Adolescents 
(IPAQ) which is publicly available atwww.ipaq.ki.se. The Arabic short form of the IPAQ 
has seven items and provides information on the PA intensity (vigorous, moderate, 
walking), duration (minutes per session), and frequency (days per week) during the 
preceding week. Two scoring protocols have been proposed by the IPAQ: categorical and 
continuous scoring. Categorical scoring suggests that respondents are to be categorized 
into one of three PA levels; high, moderate, or low using algorithms provided in the 
IPAQ scoring protocol (www.ipaq.ki.se). Continuous scoring suggests that PA levels to 
be expressed as metabolic equivalents (MET) per minute per week. The MET is a 
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physiological measure representing the energy cost of PA. One MET is defined as 1 
kcal/kg/hour and considered equivalent to the energy expended by an individual while 
sitting. MET/minute/week will be calculated using the following equation: “MET level x 
minutes of activity x events per week”. All continuous scores for vigorous, moderate and 
walking will be expressed as MET-minutes/week using the recommended values for each 
category as walking PA = 3.3 METs, moderate PA = 4.0 METs and vigorous PA = 8.0 
METs. As suggested by Ainsworth et al. (2000), the following calculation method will be 
used to yield four continuous scores:  
1. “Walking MET-minutes/week = 3.3 × walking minutes × walking days. 
2. Moderate MET-minutes/week = 4.0 × moderate-intensity activity minutes × 
moderate days. 
3. Vigorous MET-minutes/week = 8.0 × vigorous-intensity activity minutes × 
vigorous-intensity days. 
4. Total physical activity MET-minutes/week = walking + moderate + vigorous 
MET-minutes/ week scores”. 
Data management and analysis for PA will be performed using the “Guidelines 
for Data Processing and Analysis of the IPAQ” (2005). The IPAQ was tested for 
reliability and validity in 12 countries during 2000 (Craig et al., 2003). The questionnaire 
demonstrated satisfactory stability of the instrument within the same week with 
Spearman’s correlation coefficients = .80. Results on criterion validity showed moderate 
agreement between the IPAQ short-form and CSA accelerometers (Craig et al., 2003). 
Also, the instrument was tested for validity and reliability in a sample of 51 overweight 
and obese Tunisian adolescents. Evidence of test-retest reliability with 2-weeks interval 
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shows high levels of ICC (ranged from .73 to .95) indicating adequate stability of the 
instrument (Regaieg, Charfi, Yaich, Damak, & Abid, 2014). Results on convergent 
validity indicated a strong correlation between the IPAQ-A scores and pedometer step 
counts (r = .66, p < .001) (Regaieg et al., 2014). 
Adherence. Adherence will be measured using the Arabic version of The 
Summary of Diabetes Self-Care Activities–Arabic (SDSCA-Arabic), a culturally 
validated version from the original instrument; The Summary of Diabetes Self-Care 
Activities (Toobert, Hampson & Glasgow, 2000). The instrument has been successfully 
adapted for adolescents aged 12 to 18 years with T1D (Toobert et al., 2000). The 
SDSCA-Arabic is an 8-item self-report scale validated to assess the frequency of diabetes 
self-care tasks in the preceding week. The scale has four subscales as follows: exercise (2 
items); blood-glucose testing (2 items); general diet (2 items), and foot care (2 items). 
The scale measures the number of days (0-7) respondent perform each behavior with a 
total score ranges from 0-56 where higher scores indicate better adherence. The SDSCA-
Arabic was validated in a sample of patients with type 2 diabetes (T2D); however, the 
author recommends that the instrument could be used in T1D patients as it covers the 
same domains of self-management activities recommended for T1D patients (K. A. 
AlJohani, personal communication, November 21, 2016). Psychometric properties of the 
instrument were evaluated in a sample of 243 patients with T2D in Saudi Arabia 
(AlJohani, Kendall, & Snider, 2016). Evidence of reliability includes Cronbach’s alpha of 
.76, indicating internal consistency reliability, and test-retest (r = .91, p < .001) indicating 
adequate stability of the instrument (AlJohani et al., 2016). 
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Glycemic Control. HbA1c levels will be retrospectively obtained from the 
participants’ medical record. Glycemic control will be determined by calculating the 
average of the last three HbA1c values over the preceding year. 
Data Collection 
Collaboration and coordination with the clinic staff will be established prior 
screening and recruitment. To begin recruitment, a support letter will be obtained from 
the designated clinic administrator, and then the researcher and a research assistant 
(Trained nursing student) will orient the clinic staff on the study aim, recruitment, and 
inclusion criteria. The clinic staff will identify eligible participants and inform the 
researcher and/or the nursing student to approach them for potential enrollment in the 
study if the patient and parents agree. The researcher and/or the nursing student will 
approach potential participants in the presence of their parents and explain the study 
purpose and the voluntary participation prior to their consent. Once consent is gained, a 
packet containing the demographic questionnaire, the Arabic version of the PedsQL-MD, 
the Arabic version of the IPAQ, and the SDSCA-Arabic questionnaires will be given to 
each participant. A brief description will be provided by the researcher and/or the nursing 
student to inform the participant and parents about the contents of each questionnaire. 
Participants will complete the study instruments using pencil and paper while waiting to 
in the clinic’s lobby before or after their visit and will be advised to fill the questionnaires 
in a private room at the designated clinic. The required time to complete all instruments is 
estimated to be less than 20 minutes. Collected data will be entered by the researcher into 
a secure database and instruments’ scoring will be computed according to each 
instrument manual. 
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Data Analysis 
All data will be analyzed using the SPSS software (IBM SPSS Statistics, Version 
25, 2018). Categorical variables will be presented in term of percentages and counts, and 
continuous variables will be presented in term of means and standard deviations (SD). 
Aim 1: Examine the association between PA and glycemic control in Jordanian 
adolescents with T1D. Hypothesis 1.1: Adolescents having high PA levels would have a 
glycemic control ≤ 7.5% as measured by HbA1c, independent of age and disease 
duration. This hypothesis will be tested using Pearson product-moment correlation 
coefficient.  
Aim 2: Evaluate HRQoL of Jordanian adolescents with T1D and examine gender 
and its association with glycemic control. Hypothesis 2.1: There are significant gender 
differences in adolescent HRQoL (specifically, girls have poorer self-rated HRQoL than 
boys), independent of age and disease duration. This hypothesis will be tested by using 
independent sample t-test to compare the means of HRQoL for females and males 
adolescents of the total sample and in each subgroup. Hypothesis 2.2: Adolescents having 
low HRQoL scores would exhibit high levels of glycemic control (HbA1c ≥ 9%), 
independent of age and disease duration. This hypothesis will be tested by using Pearson 
product-moment correlation coefficient. 
Aim 3: Examine the association between regimen adherence and glycemic control 
in Jordanian adolescents with T1D. Hypothesis 3.1: Adolescents with high adherence 
scores would have a glycemic control ≤ 7.5% as measured by HbA1c, independent of age 
and disease duration. This hypothesis will be tested by using Pearson product-moment 
correlation coefficient.  
20 
 
 
 
Aim 4: Examine the interaction between PA, HRQoL, and adherence in the 
prediction of glycemic control in Jordanian adolescents with T1D.  Hypothesis 4.1: The 
HRQoL will interact with adherence in the prediction of glycemic control with higher 
scores in both variables predict a glycemic control of ≤ 7.5% as measured by HbA1c. 
Hypothesis 4.2: The HRQoL will interact with PA in the prediction of glycemic control 
with higher scores in both variables predict a glycemic control of ≤ 7.5% as measured by 
HbA1c. Hypothesis 4.3: There will be no interaction between PA and adherence in the 
prediction of glycemic control in Jordanian adolescents with T1D. These three 
hypotheses will be tested using multiple linear regression tests. All regression models 
will be adjusted for age, gender, and disease duration. A P value of ˂.05 will be 
considered statistically significant in all of the analyses. 
Study Limitations 
There are several potential limitations in this study such as sampling technique 
and sample size. Participants will be recruited non-randomly which may yield a non-
representative sample of the study population. The estimated sample size (N=74) is 
considered small, and it may be difficult to find significant correlations between the study 
variables. Since the primary researcher will retrieve the latest three readings of HbA1c 
for each participant, there may be some missing data which may limit the scope of our 
analysis. The utilization of a cross-sectional design will limit generalizability but this 
pilot study will help to inform future studies with larger samples using the information 
provided by this study. 
Human Subjects 
Permission to conduct the study will be obtained from the Institutional Review 
Board (IRB) of The University of Texas Health Science Center at Houston, and from the 
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IRB of King Abdullah University Hospital where the study will be conducted. Human 
subjects’ procedures include the recruitment procedure, the eligibility screening process, 
completing the study questionnaires, and accessing the medical files to obtain the HbA1c 
values. The study will include both male and female adolescents with T1D. 
After consent is obtained from adolescents and their parents, data collection will 
include gathering information from participants’ medical records and questionnaires 
filling that will be used for research purposes only. Participants will be provided with 
information on the voluntary nature of participation, potential benefits, risks, and the use 
of the gathered information. In general, it is anticipated that the risks associated with 
enrollment in the study are of low risk. However, there is always a risk of a breach of 
confidentiality. All participants will be advised to fill the questionnaires in a private room 
at the designated clinic. IRB approval will be obtained prior to any communication with 
the participants. All participants will not be approached if their parents are not in 
attendance or unavailable. Participant’s rights, needs, values, reputation, and 
confidentiality will be upheld by the researcher. Subjects who meet the inclusion criteria 
and willing to participate in the study will be given an informed consent to be signed by 
the adolescent and his/her parents. All participants will also be informed that if they no 
longer wish to participate for whatever reason, they could withdraw from the study at any 
time. Informed consent will be obtained from all adolescents and their parents, and the 
list of eligible subjects and completed data will be stored in a locked drawer cabinet free 
from potential breach. There are no direct benefits from participation in the study; 
however, findings of the study may help health care providers on national and 
international levels to better understand the influential role of PA, HRQoL, and 
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adherence on the glycemic control which may help them to provide better management 
and care. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 
 
 
 
References 
Abdul-Rasoul, M., AlOtaibi, F., Abdulla, A., Rahme, Z., & AlShawaf, F. (2013). 
Quality of life of children and adolescents with type 1 diabetes in Kuwait. 
Medical Principles and Practice: International Journal of the Kuwait University, 
Health Science Centre, 22(4), 379. 
Ainsworth, B. E., Haskell, W. L., Whitt, M. C., Irwin, M. L., Swartz, A. M., Strath, S. 
J., . . . Leon, A. S. (2000). Compendium of physical activities: An update of 
activity codes and MET intensities. Medicine and Science in Sports and Exercise, 
32(9 Suppl), S498. 
Ajlouni, H., Ajlouni, K., Khader, Y. S., Batieha, A., & El-Khateeb, M. (2008). An 
increase in prevalence of diabetes mellitus in Jordan over 10 years. Journal of 
Diabetes and its Complications, 22(5), 317-324. 
doi:10.1016/j.jdiacomp.2007.01.004 
Al-Akour, N., Khader, Y. S. & Shatnawi, N. J. (2010). Quality of life and associated 
factors among Jordanian adolescents with type 1 diabetes mellitus. Journal of 
Diabetes Complications, 24(1):43-47. doi: 10.1016/j.jdiacomp 
Al-Hayek, A. A., Robert, A. A., Abbas, H. M., Itani, M. B., Al-Saeed, A. H., Juhani, 
A. E., . . . Al-Sabaan, F. S. (2014). Assessment of health-related quality of life 
among adolescents with type 1 diabetes mellitus in Saudi Arabia. Saudi Medical 
Journal, 35(7), 712.  
AlJohani, K. A., Kendall, G. E., & Snider, P. D. (2016). Psychometric evaluation of 
the summary of diabetes self-care Activities–Arabic (SDSCA-Arabic): 
24 
 
 
 
Translation and analysis process. Journal of Transcultural Nursing, 27(1), 65-72. 
doi:10.1177/1043659614526255 
Aman, J., Skinner, T. C., de Beaufort, C. E., Swift, P. G. F., Aanstoot, H., Cameron, 
F., . . . Hälsoakademin. (2009). Associations between physical activity, sedentary 
behavior, and glycemic control in a large cohort of adolescents with type 1 
diabetes: The Hvidoere study group on childhood diabetes. Pediatric Diabetes, 
10(4), 234-239.  
American Association of Diabetes Educators. (2014). AADE7™ Self-Care Behaviors. 
Retrieved from https://www.diabeteseducator.org/docs/default-source/legacy 
docs/_resources/pdf/publications/aade7_position_statement_final.pdf?sfvrsn=4. 
American Diabetes Association. (2014). Standards of medical care in diabetes-2014. 
Diabetes Care, 37Suppl 1(1), S14-S80. doi:10.2337/dc14-S014 
Borus, J. S., & Laffel, L. (2010). Adherence challenges in the management of type 1 
diabetes in adolescents: prevention and intervention. Current Opinion in 
Pediatrics, 22(4), 405–411. http://doi.org/10.1097/MOP.0b013e32833a46a7 
Centers for Disease Control and Prevention. (2014).National Diabetes Statistics 
Report. Retrieved from https://www.cdc.gov/diabetes/pubs/statsreport14/national-
diabetes-report-web.pdf. 
Cheng, A. Y. Y, & Canadian Diabetes Association Clinical Practice Guidelines 
Expert Committee. (2013). Canadian diabetes association 2013 clinical practice 
25 
 
 
 
guidelines for the prevention and management of diabetes in Canada. 
Introduction. Canadian Journal of Diabetes, 37 Suppl 1. 
Chimen, M., Kennedy, A., Nirantharakumar, K., Pang, T. T., Andrews, R., & 
Narendran, P. (2012). What are the health benefits of physical activity in type 1 
diabetes mellitus? A literature review. Diabetologia, 55(3), 542-551. 
doi:10.1007/s00125-011-2403-2 
Clarke, S., & Eiser, C. (2004). The measurement of health-related quality of life 
(QOL) in pediatric clinical trials: A systematic review. Health and Quality of Life 
Outcomes, 2(1), 66-66. doi:10.1186/1477-7525-2-66 
Compas, B. E., Jaser, S. S., Dunn, M. J., & Rodriguez, E. M. (2012). Coping with 
Chronic Illness in Childhood and Adolescence. Annual Review of Clinical 
Psychology, 8, 455–480. http://doi.org/10.1146/annurev-clinpsy-032511-143108. 
Cox, L., & Hunt, J. (2015). Factors that affect adolescents’ adherence to diabetes 
treatment: Laura Cox and Jane hunt identify individual and combinations of 
factors, such as parental and peer attitudes that influence the extent to which 
young people adhere to medication regimens. Nursing Children and Young 
People, 27(1), 16-21. doi:10.7748/ncyp.27.1.16.e565 
Craig, C. L., Marshall, A. L., Sjöström, M., Bauman, A. E., Booth, M. L., Ainsworth, 
B. E., . . .Oja, P. (2003). International physical activity questionnaire: 12-country 
reliability and validity. Medicine and Science in Sports and Exercise, 35(8), 1381-
1395. doi:10.1249/01.MSS.0000078924.61453.FB 
26 
 
 
 
Curtis, A. C. (2015). Defining Adolescence. Journal of Adolescent and Family 
Health, 7(2), Available at: http://scholar.utc.edu/jafh/vol7/iss2/2 
Da Costa, L. M. F. C., & Vieira, S. E. (2015). Quality of life of adolescents with type 
1 diabetes. Clinics, 70(3), 173–179. http://doi.org/10.6061/clinics/2015(03)04 
Dajani, R., Khader, Y. S., Fatahallah. R., El-Khateeb, M., Shiyab. A. H. & Hakooz N. 
(2012). Diabetes mellitus in genetically isolated populations in Jordan: 
prevalence, awareness, glycemic control, and associated factors. J Diabetes 
Complications, 26(3), 175–180. doi: 10.1016/j.jdiacomp 
Demirel, F., Tepe, D., Kara, Ö., & Esen, İ. (2013). Microvascular Complications in 
Adolescents with Type 1 Diabetes Mellitus. Journal of Clinical Research in 
Pediatric Endocrinology, 5(3), 145–149. http://doi.org/10.4274/Jcrpe.994 
Elhadd, T. A., Al-Amoudi, A. A., & Alzahrani, A. S. (2007). Epidemiology, clinical 
and complications profile of diabetes in Saudi Arabia: A review. Annals of Saudi 
Medicine, 27(4), 241. 
Galler, A., Lindau, M., Ernert, A., Thalemann, R., & Raile, K. (2011). Associations 
between media consumption habits, physical activity, socioeconomic status, and 
glycemic control in children, adolescents, and young adults with type 1 diabetes. 
Diabetes Care, 34(11), 2356-2359. doi:10.2337/dc11-0838 
García-Pérez, L.-E., Álvarez, M., Dilla, T., Gil-Guillén, V., & Orozco-Beltrán, D. 
(2013). Adherence to Therapies in Patients with Type 2 Diabetes. Diabetes 
Therapy, 4(2), 175–194. http://doi.org/10.1007/s13300-013-0034-y. 
27 
 
 
 
Garrison W., Felice M. E. (2009). Adolescence. In Carey W. B., Crocker A. C., 
Coleman W. L., Elias E. R., Feldman H. M. (Eds.), Developmental-behavioral 
pediatrics (4th ed., pp. 62–73). Philadelphia, PA: Saunders. 
Hanas, R., John, G., & on behalf of the International HbA1c Consensus Committee. 
(2010). 2010 consensus statement on the worldwide standardization of the 
hemoglobin A1C measurement: 2010 HbA1c consensus. Diabetic Medicine, 
27(7), 737-738. doi:10.1111/j.1464-5491.2010.03033.x 
Helgeson, V. S., Becker, D., Escobar, O., & Siminerio, L. (2012). Families with 
children with diabetes: Implications of parent stress for parent and child health. 
Journal of Pediatric Psychology, 37(4), 467-478. doi:10.1093/jpepsy/jsr110 
Herbst, A., Bachran, R., Kapellen, T., &Holl, R. W. (2006). Effects of regular 
physical activity on control of glycaemia in pediatric patients with type 1 diabetes 
mellitus. Archives of Pediatrics & Adolescent Medicine, 160(6), 573-577. 
doi:10.1001/archpedi.160.6.573 
Herbst, A., Kordonouri, O., Schwab, K. O., Schmidt, F., Holl, R. W., DPV Initiative 
of the German Working Group for Pediatric Diabetology Germany, & on behalf 
of the DPV Initiative of the German Working Group for Pediatric Diabetology 
Germany. (2007). Impact of physical activity on cardiovascular risk factors in 
children with type 1 diabetes: A multicenter study of 23,251 patients. Diabetes 
Care, 30(8), 2098-2100. doi:10.2337/dc06-2636 
Huang, G., Palta, M., Allen, C., LeCaire, T., D'Alessio, D., & Wisconsin Diabetes 
Registry. (2004). Self-rated health among young people with type 1 diabetes in 
28 
 
 
 
relation to risk factors in a longitudinal study. American Journal of Epidemiology, 
159(4), 364-372.  
Irwin, C. E., Burg, S. J., & Cart, C. U. (2002). America's adolescents: Where have we 
been, where are we going? Journal of Adolescent Health, 31, 91-121. 
Jaser, S. S., Faulkner, M. S., Whittemore, R., Jeon, S., Murphy, K., Delamater, A., & 
Grey, M. (2012). Coping, self-management, and adaptation in adolescents with 
type 1 diabetes. Annals of Behavior Medicine, 43, (3), 311–319. doi: 
10.1007/s12160-012-9343-z 
Kennedy, A., Nirantharakumar, K., Chimen, M., Pang, T. T., Hemming, K., Andrews, 
R. C., & Narendran, P. (2013). Does exercise improve glycemic control in type 1 
diabetes? A systematic review and meta-analysis. PloS One, 8(3), e58861. 
Livingstone, S. J., Looker, H. C., Hothersall, E. J., Wild, S. H., Lindsay, R. S., 
Chalmers, J., . . . Colhoun, H. M. (2012). Risk of cardiovascular disease and total 
mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS 
Medicine, 9(10), e1001321. doi:10.1371/journal.pmed.1001321 
Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. (2010). Chapter 1: 
Epidemiology of Type 1 Diabetes. Endocrinology and Metabolism Clinics of 
North America, 39(3), 481–497. http://doi.org/10.1016/j.ecl.2010.05.011 
Memon, A., Polack, S., Al-Khawari, M., Qabazard, M., Al-Adsani, A., Abdul-Rasoul, 
M., . . . Suresh, A. (2014). PP11 association between atopic disorders and 
childhood type 1 diabetes: A population-based case control study in the Middle 
29 
 
 
 
East. Journal of Epidemiology and Community Health, 68(Suppl 1), A51-A51. 
doi:10.1136/jech-2014-204726.108 
Nordfeldt, S., Ängarne-Lindberg, T., Nordwall, M., Krevers, B., Institutionen 
förmedicinochhälsa, Hälsouniversitetet, . . .Avdelningenförhälso- 
ochsjukvårdsanalys. (2013). Parents of adolescents with type 1 diabetes--their 
views on information and communication needs and internet use. A qualitative 
study. PloS One, 8(4), e62096. doi:10.1371/journal.pone.0062096 
Office of Disease Prevention and Health Promotion. (2016). Diabetes. In Healthy 
People 2020. Retrieved from https://www.healthypeople.gov/2020/topics-
objectives/topic/diabetes/objectives 
Overby, N. C., Margeirsdottir, H. D., Brunborg, C., Anderssen, S. A., Andersen, L. 
F., Dahl-Jørgensen, K., & Norwegian Study Group for Childhood Diabetes. 
(2009). Physical activity and overweight in children and adolescents using 
intensified insulin treatment. Pediatric Diabetes, 10(2), 135-141. 
doi:10.1111/j.1399-5448.2008.00454.x 
Özyazıcıoğlu, N., Avdal, E. Ü., & Sağlam, H. (2017). A determination of the quality 
of life of children and adolescents with type 1 diabetes and their parents. 
International Journal of Nursing Sciences, doi:10.1016/j.ijnss.2017.01.008 
Patton, S. R. (2011). Adherence to Diet in Youth with Type 1 Diabetes. Journal of the 
American Dietetic Association, 111(4), 550 555.  Error! Hyperlink reference not 
valid. 
30 
 
 
 
Quirk, H., Blake, H., Tennyson, R., Randell, T. L., & Glazebrook, C. (2014). Physical 
activity interventions in children and young people with type 1 diabetes mellitus: 
A systematic review with meta‐analysis. Diabetic Medicine, 31(10), 1163-1173. 
doi:10.1111/dme.12531 
Radzik, M., Sherer, S., & Neinstein, L. S. (2002). Psychosocial development in 
normal adolescents. In L. S. Neinstein (Ed.), Adolescent health care: A practical 
guide (4th ed., pp.52-58). Philadelphia: Lippincott. 
Regaieg, S., Charfi, N., Yaich. S., Damak. J., & Abid, M. (2014). The Reliability and 
Concurrent Validity of a Modified Version of the International Physical Activity 
Questionnaire for Adolescents (IPAQ-A) in Tunisian Overweight and Obese 
Youths. Medical Principles and Practice, 25:227-232. 
Soliman, A. T., al-Salmi, I. S., & Asfour, M. G. (1996). Epidemiology of childhood 
insulin-dependent diabetes mellitus in the sultanate of Oman. Diabetic Medicine: 
A Journal of the British Diabetic Association, 13(6), 582. 
Steinberg, L. (2014). Age of opportunity: Lessons from the new science of 
adolescence. New York: Springer US. doi:10.1007/s10964-015-0277-1 
Tielemans, S. M. A. J., Soedamah-Muthu, S. S., Neve, D., M, Toeller, M., 
Chaturvedi, N., Fuller, J. H., & Stamatakis, E. (2013). Association of physical 
activity with all-cause mortality and incident and prevalent cardiovascular disease 
among patients with type 1 diabetes: The EURODIAB prospective complications 
study. Diabetologia, 56(1), 82-91. doi:10.1007/s00125-012-2743-6 
31 
 
 
 
Toobert, D. J., Hampson, S. E., & Glasgow, R. E. (2000). The summary of diabetes 
self-care activities measure: Results from 7 studies and a revised scale. Diabetes 
Care, 23(7), 943-950. doi:10.2337/diacare.23.7.943 
Usher-Smith, J. A., Thompson, M., Ercole, A., & Walter, F. M. (2012). Variation 
between countries in the frequency of diabetic ketoacidosis at first presentation of 
type 1 diabetes in children: A systematic review. Diabetologia, 55(11), 2878-
2894. doi:10.1007/s00125-012-2690-2 
Varni, J. W., Burwinkle, T. M., Jacobs, J. R., Gottschalk, M., Kaufman, F., & Jones, 
K. L. (2003). The PedsQL™ in type 1 and type 2 diabetes. Diabetes Care, 26(3), 
631. doi:10.2337/diacare.26.3.631 
Varni, J. W., Burwinkle, T. M., Jacobs, J. R., Gottschalk, M., Kaufman, F., & Jones, 
K. L. (2003). The PedsQL in type 1 and type 2 diabetes: Reliability and validity 
of the pediatric quality of life inventory generic core scales and type 1 diabetes 
module. Diabetes Care, 26(3), 631. 
Wild, D., von Maltzahn, R., Brohan, E., Christensen, T., Clauson, P., & Gonder-
Frederick, L. (2007). A critical review of the literature on fear of hypoglycemia in 
diabetes: Implications for diabetes management and patient education. Patient 
Education and Counseling, 68(1), 10-15. doi:10.1016/j.pec.2007.05.003 
Wolfsdorf, J. I., Allgrove, J., Craig, M. E., Edge, J., Glaser, N., Jain, V., . . . 
International Society for Pediatric and Adolescent Diabetes. (2014). ISPAD 
clinical practice consensus guidelines 2014. Diabetic ketoacidosis and 
hyperglycemic hyperosmolar state. Pediatric Diabetes, 15 Suppl 20, 154. 
32 
 
 
 
World Health Organization. Evidence for Action-Adherence to Long-term Therapies 
for Chronic Conditions. Geneva: World Health Organization Publications, 2003 
World Health Organization. Young people’s health – a challenge for society Report of 
a Study Group on Young People and Health for All by the Year 2000. Geneva: 
World Health Organization, 1986. 
Zayed, H. (2016). Genetic epidemiology of type 1 diabetes in the 22 Arab countries. 
Current Diabetes Reports, 16(5), 37. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
 
 
 
 
ASSOCIATIONS BETWEEN PHYSICAL ACTIVITY, HEALTH-RELATED 
QUALITY OF LIFE, REGIMEN ADHERENCE, AND GLYCEMIC CONTROL IN 
JORDANIAN ADOLESCENTS WITH TYPE 1 DIABETES 
__________________________________________ 
A DISSERTATION 
SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIRMENTS 
FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN NURSING 
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON 
CIZIK SCHOOL OF NURSING 
BY 
YOUSEF M. ALJAWARNEH, Ph.D.(c), M.C.B., R.N.   
__________________________________________ 
MAY, 2018
34 
 
 
 
87 
8
7 
Abstract 
Background: Adolescents with Type 1 Diabetes (T1D) display a greater than two-fold 
higher risk of developing microvascular and macrovascular complications compared with 
the non-diabetic population and the risk increases markedly as glycated hemoglobin 
(HbA1c) increases. The majority of the findings on the associated factors with improved 
glycemic control are geared toward Western population with a clear lack of studies on 
Middle Eastern populations. Purpose: This study aimed to examine the effect of Physical 
Activity (PA), Health-Related Quality of Life (HRQoL), and regimen adherence on 
glycemic control in Jordanian adolescents with T1D.  Methods: The study utilized a 
cross-sectional design. Jordanian adolescents (aged 12-18) with T1D (n=74) were 
recruited. Self-reported measures were used including the Pediatric Quality of Life-
Diabetes Module, the International Physical Activity Questionnaire, and the Summary of 
Diabetes Self-Care Activities. HbA1c values were obtained from the medical records. 
Correlation analyses were conducted using Pearson’s and Spearman’s correlation tests. 
Multiple regression analyses were conducted to determine if HRQoL, PA, and regimen 
adherence predict glycemic control. Results: Only 14.8% of the participants 
demonstrated good glycemic control (HbA1c ≤ 7.5%). Participants with poor control had 
a statistically significant lower mean PA of MET-minutes/week (3531.9 ± 1356.75 vs. 
1619.81 ± 1481.95, p < .001) compared to those with good control. The total sample was 
found to demonstrate low HRQoL (47.70 ± 10.32).  Participants were within the 
acceptable range of PA (1885.38 ±1601.13) MET-minutes/week. HbA1c significantly 
inversely correlated with PA (r = -.328, p = .010) and regimen adherence (r = -.299, p = 
.018). Regimen adherence and PA significantly predicted HbA1c in the unadjusted 
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regression model (β = -.367, p < .01; β = -.409, p < .01) and after adjustment for age and 
disease duration (β = -.360, p < .01; β = -.475, p < .01). In the interaction model, the 
interaction between PA and regimen adherence was statistically significant (β = -.304, p 
< .05).  Conclusion: Better glycemic control was significantly predicted by higher PA 
and regimen adherence levels. There was no significant association between glycemic 
control and HRQoL. Further research is needed to provide more information on 
psychosocial and cultural factors that impact glycemic control and quality of life in this 
population. 
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Background 
Type 1 diabetes (T1D) is an organ-specific autoimmune disease that occurs when 
the insulin-producing pancreatic beta cells are destroyed by the immune system, leading 
to a chronic deficiency of insulin hormone in genetically susceptible individuals. The 
insulin deficiency results in decreased insulin utilization and increased hepatic glucose 
production leading to hyperglycemia (Echeverri & Tobón, 2013). According to the 
American Diabetes Association (ADA) (2017), the diagnosis and classification of T1D is 
usually confirmed in symptomatic patients with a markedly raised random blood glucose 
finding of  ≥ 200 mg/dl (11.1 mmol/L) accompanied by clinical symptoms of polydipsia, 
polyuria, weight loss, ketonuria , and marked hyperglycemia (Marathe, Gao, & Close, 
2017). Once the diagnosis is confirmed, serum concentration of the glycated hemoglobin 
(HbA1c) level is used as a standard measure to assess therapeutic effectiveness and to 
determine how long a patient has had hyperglycemia (Marathe et al., 2017). 
Type 1 diabetes is a serious illness associated with significant morbidity and 
mortality because of its both acute and long-term complications (Demirel, Tepe, Kara, & 
Esen, 2013). Diabetes-related macro and microvascular complications as cardiovascular 
diseases, retinopathy, and nephropathy are life-threatening problems with significant 
impacts on quality of life in children and adolescents with T1D (Demirel et al., 2013; 
Donaghue et al., 2014; Dabelea et al., 2017). Adolescents with T1D display a greater than 
two-fold higher risk of developing microvascular complications and cardiovascular 
disease compared with the non-diabetic population (Cho et al., 2011; De Ferranti et al., 
2014) and the risk increases markedly as HbA1c increases (Virk et al., 2016). Despite the 
fact that the recommended level of HbA1c of less than 7.5% is generally associated with 
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decreased risk of diabetes-associated complications compared with higher levels, few 
adolescents with T1D achieved this target (Livingstone et al., 2012). Therefore, T1D 
treatment guidelines intensify controlled blood glucose levels and glycemic status to 
minimize the risk of macrovascular and microvascular complications (Cheng et al., 2013; 
Demirel et al., 2013). The recommended treatment regimen for T1D includes daily blood 
glucose measurement, daily insulin injections or using an insulin pump, monitoring and 
controlling carbohydrate intake, and performing physical activities (Marathe et al., 2017). 
Globally there is a consistently increasing trend in the incidence of T1D (Egro, 
2013) with a clear variation in the prevalence and incidence between countries (Maahs, 
West, Lawrence, & Mayer-Davis, 2010). For instance, about 1.25 million Americans are 
living with T1D including about 200,000 youth (less than 20 years old). The number is 
expected to increase 4 folds (5 million people) by 2050 including nearly 600,000 youth 
(Centers for Disease Control and Prevention, 2014). In the Arab world, there is clear 
epidemiological evidence that the incidence of T1D is high (Elhadd, Al-Amoudi, & 
Alzahrani, 2007), particularly in the Gulf region with large variations in the incidence, 
ranging from low in Oman (2.54/100,000) (Soliman, al-Salmi, & Asfour, 1996) to high in 
Saudi Arabia (29/100,000) (Habeb et al., 2011). Relatively, Jordan has a low incidence of 
T1D but the rate is increasing (Ajlouni, Khader, Batieha, & El-Khateeb, 2008). 
Purpose Statement 
Adolescence is a theoretical construct that is dynamically evolved through 
biological, psychological, and socio-cultural perspectives (Curtis, 2015). The 
chronological definition of adolescence describes the period as the years starting from 
puberty to the onset of social independence (Steinberg, 2014). Given the critical 
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developmental, emotional, cognitive, and social changes that occur during adolescence, 
the presence of a chronic condition during this period can lead to significant anxiety and 
stress that is associated with risk for emotional and behavioral problems that interferes 
with regimen adherence (Compas, Jaser, Dunn, & Rodriguez, 2012). If diabetes care is 
not executed well, adolescents with T1D can face both acute and chronic complications 
(Usher-Smith, Thompson, Ercole, & Walter, 2012). 
Type 1 Diabetes and Glycemic Control 
Glycated hemoglobin is a biometric index of the percentage of the three-month 
average plasma glucose concentration. The standardized HbA1c test is widely accepted 
and used to evaluate the glycemic control and diabetes care. According to the ADA 
Standards of Medical Care in Diabetes (2017), the target of HbA1c for adolescents with 
T1D is recommended to be below 7.5% (58 mmol/L) (Marathe et al., 2017). The benefits 
of maintaining stable and controlled glycemic status among T1D patients are well 
documented. Furthermore, the earlier the HbA1c level is lowered, the greater the benefits 
are optimized. The results from the Epidemiology of Diabetes Interventions and 
Complications (EDIC) study and the Diabetes Control and Complications Trial (DCCT) 
indicated that constantly increased HbA1c for 5-7 years during adolescence results in an 
increased risk for diabetes-related complications in the next 6 to 10 years on age (Steffes 
et al., 2003; Dovc et al., 2014).  
Type 1 Diabetes and Physical Activity 
Physical activity (PA) has been considered an essential component of the 
management of T1D. Physical activity is broadly defined as “as any movement of 
skeletal muscle that results in energy expenditure above resting levels, whereas exercise 
39 
 
 
 
87 
8
7 
is a subset of physical activity where the engagement of skeletal muscle in movement is 
planned, structured, repetitive, and for the purpose of training, fitness or developing a 
sports skill” (Annan, 2013, p. 234). When considering the role of exercise in T1D, it is 
important to understand that the insulin secretion is independent of counter-regulatory 
hormonal response during exercise; therefore, blood glucose regulation is not well 
controlled during exercise due to the complete absence of the physiological suppression 
of insulin which leads to inadequate muscular uptake of glucose. Therefore PA in 
children and adolescents with T1D may induce hyperglycemia and hypoglycemia events 
during and after exercise (Iughetti, Gavioli, Bonetti, & Predieri, 2015). Hence, several 
factors must be considered when planning PA for children and adolescents with T1D 
including type, duration, intensity, and timing of the exercise, number of muscles used in 
the exercise, glycemic control, frequency of insulin injections, type of food, frequency of 
daily meals, and blood glucose level (Robertson et al., 2015). 
For instance, the type of exercise such as aerobic and resistance training exercises 
can contribute to a wide range of blood glucose responses (Turner et al., 2016). Exercise 
duration also has a vital impact on blood glucose outcomes in patients with T1D, with 
longer durations generally resulting in greater risk of hypoglycemia during and after 
exercise (Turner et al., 2015). Therefore, balancing all of these variables can be 
predominately challenging for children and adolescents with T1D who choose to be more 
active to avoid exercise-induced complications (Brazeau, Rabasa-Lhoret, Strychar, & 
Mircescu, 2008). 
The ADA (2017) guidelines indicates that children and adolescents with T1D 
perform at least one hour of moderate-vigorous physical activity (MVPA) on daily basis. 
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These general guidelines are directed toward a combined form of PA including moderate 
and vigorous activities that enhance the cardiovascular, musculoskeletal, and metabolic 
functionality (Pivovarov, Taplin, & Riddell, 2015). In T1D adolescents with good 
glycemic control, regular PA has been found to increase cardiovascular fitness, reduce 
cardiovascular risk factors, decrease daily insulin doses, and enhance psychosocial well-
being (Chimen, Kennedy, Nirantharakumar, Pang, Andrews, & Narendran, 2012). 
Despite the associated benefits, adolescents with T1D were commonly reported to be less 
active compared with non-diabetic peers which contribute to macrovascular and 
microvascular risks (Lukacs, Mayer, Juhasz, Varga, Fodor, & Barkai, 2012; Leroux, 
Brazeau, Gingras, Desjardins, Strychar, & Rabasa-Lhoret, 2014). Several observational 
studies found that the lower prevalence, incidence, severity, and complications of T1D in 
adolescents were associated with higher levels of PA (Tielemans et al., 2013; Kennedy et 
al., 2013).  
The evidence for the effect of PA on glycemic control is ambiguous.  For 
instance, some studies reported improvement in glycemic control with increased levels of 
daily PA in adolescents with T1D (Schweiger, Klingensmith, & Snell-Bergeon, 2010), 
but others have not found any association (Aman et al., 2009; Galler, Lindau, Ernert, 
Thalemann, & Raile, 2011). Several other studies found an inverse correlation between 
PA and HbA1c levels (Herbst et al., 2007; Herbst, Bachran, Kapellen, & Holl, 2006). 
Similarly, several meta-analyses reported contradictory results. While Quirk and 
colleagues (2014) suggested an improvement in the glycemic status of physically active 
adolescents with T1D, Kennedy and colleagues (2013) did not find any association 
between glycemic control and PA in adolescents with T1D. 
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Type 1 Diabetes and Health-Related Quality of Life 
Health-Related Quality of Life (HRQoL) is a multidimensional concept that 
describes the social, physical, mental, and emotional well-being and reflects how the 
effects and treatment of diseases are perceived (Clarke & Eiser, 2004). According to the 
International Society for Pediatric and Adolescent Diabetes (ISPAD) clinical practice 
consensus guidelines (2014), evaluation of HRQoL is considered an essential component 
in order to determine disease progression and type of insulin regimen that would be 
efficient to maintain the recommended glycemic control with decreased impact on 
HRQoL (Delamater et al., 2014). Enhancing the HRQoL of adolescents with T1D has 
been suggested to be a paramount factor in preventing diabetes complications and disease 
morbidities (Da Costa & Vieira, 2015).While the care of T1D requires high levels of 
shared responsibilities and self-control to achieve the recommended glycemic control, 
several studies reported that children and adolescents who are of older age, living with a 
single parent, and lower family income exhibit poor glycemic control and worse HRQoL 
(Delamater et al., 2014; Özyazıcıoğlu, Avdal, & Sağlam, 2017). 
Type 1 Diabetes and Regimen Adherence 
Only 21% of adolescents with T1D were reported to meet the ADA guidelines for 
the recommended HbA1c level in the United States of America (USA) (Wood et al., 
2013). The association between regimen adherence and glycemic control suggests that 
regimen adherence must be maximized in order to control glycemic status (Hood, 
Peterson, Rohan & Drotar, 2009). Furthermore, regimen adherence and glycemic control 
are known to substantially deteriorate during adolescence (Rausch et al., 2012). 
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Regimen adherence is broadly defined as “the degree to which patients follow the 
recommendations of their health professionals” (Kelly & DiMatteo, 2009, p.826). In 
patients with T1D, these recommendations include measuring blood glucose four to six 
times per day, regulating carbohydrates intake, taking insulin therapy as needed, 
performing physical exercises, and attending routine clinic appointments (ADA, 2017). 
Considering technologic advancement in diabetes management, data indicate that 
adherence to therapy challenges even the most competent and motivated adolescent and 
continues to be a problem (Borus & Laffel, 2010). For example, data from a large cross-
sectional study (N= 17,317) indicated that using new diabetes care technologies such as 
continuous blood glucose monitoring was associated with lower HbA1c (8.3% vs. 8.6%, 
p <.001), however, participants rarely used the technology to measure and report their 
daily blood glucose (Wong et al., 2014). Furthermore, the findings from a meta-analysis 
of 21 studies included 2,429 adolescents with T1D supported that better treatment 
adherence predicts improved glycemic control independent of demographic factors such 
as race, ethnicity, income, and single parenthood (Hood et al., 2009). In contrast, 
adolescents who demonstrated better adherence have better glycemic control and fewer 
diabetes complications compared with adolescents who less frequently engaged in 
adherence behaviors (Patton, 2015). Therefore, these findings reinforce the fact that 
regimen adherence is a core prerequisite to improve glycemic control in adolescents with 
T1D. 
Statement of the Problem 
Macrovascular and microvascular complications remain the major cause of 
morbidity and mortality in patients with T1D (You & Henneberg, 2016). Considering the 
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efforts made by many well-established agencies such as the World Health Organization 
(WHO), the International Society for Pediatric and Adolescent Diabetes (ISPAD), and 
the American Diabetes Association (ADA), through establishing, updating, and 
publishing treatment guidelines, and recommending which treatment protocol is more 
effective for T1D patients, implementation and utilization of these protocols still 
underestimations. 
Poor glycemic control in adolescents with T1D can affect growth and expose 
adolescents to frequent episodes of hypoglycemia which can adversely impair 
neurological development (Usher-Smith et al., 2012). Additionally, there are relatively 
sufficient information in the literature on various demographic and clinical factors that 
are reported to be predictors of glycemic control such as age, gender, disease duration 
(Clements et al., 2014; Åkesson et al., 2015; Esdonk, Tai, Cotterill, Charles, & Hennig, 
2017), body mass index (BMI) (Bae, Lage, Mo, Nelson, & Hoogwerf, 2016; Vaid, 
Hanks, Griffin, & Ashraf, 2016), insulin requirements (Beato-Víbora & Tormo-García, 
2014), and carbohydrates counting (Bell, Barclay, Petocz, Colagiuri, & Brand-Miller, 
2014). In contrast, information on the psychosocial, physical, and emotional factors that 
may affect glycemic control is not well studied and the available findings are 
controversial. Furthermore, the traditional concept of relying heavily on pharmacological 
components to minimize and prevent medical complications has been shifted to 
emphasize the importance of including all health dimensions including social, 
psychological, and emotional components of patients’ life. Therefore, it is vitally 
important to gear research toward investigating other factors that may influence glycemic 
44 
 
 
 
87 
8
7 
control and consequently improve the quality of life and clinical outcome in the T1D 
adolescent population.  
Furthermore, adolescents with T1D are clearly understudied in the Middle East 
and particularly in Jordan, with only one study conducted in 2010 that reported low levels 
of HRQoL in Jordanian adolescents with T1D (Al-Akour, Khader & Shatnawi, 2010). 
The majority of research on adolescents with T1D has been conducted in Westren 
counries. Given the differences in health care delivery systems, lifestyles, religion, 
cultural components, and family structure and dynamics in different countries, the 
findings of these existing studies may not be generalizable to Middle Eastern adolescents. 
Therefore, it is important to study the influence of PA, HRQoL, and regimen adherence 
on the glycemic control and subsequently the clinical outcomes in this population.   
Purpose 
The purpose of this cross-sectional study was to examine the effect of PA, 
HRQoL, and regimen adherence on glycemic control in Jordanian adolescents (aged 12-
18) with T1D. Since cultural differences in family structure and lifestyle fundamentally 
vary between adolescents from different countries, the findings of this study were 
intended to provide needed insight on how these factors could explain and influence on 
metabolic outcomes differently, that in turn will enable researchers and clinicians to 
provide culturally-tailored interventions that promote and enhance these factors thereby 
positively improve clinical outcomes of this culturally unified population. 
Specific Aims and Hypotheses 
The specific aims and hypotheses were: 
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1) Examine the association between PA and glycemic control in Jordanian 
adolescents with T1D. 
It was hypothesized that PA would negatively correlate with glycemic control, 
and adolescents having high PA levels would have a glycemic control ≤ 7.5% as 
measured by HbA1c, independent of age and disease duration. 
2) Evaluate HRQoL of Jordanian adolescents with T1D and examine gender 
and its association with glycemic control. 
It was hypothesized that HRQoL would negatively correlate with glycemic 
control, and adolescents having low HRQoL scores would exhibit high levels of glycemic 
control (HbA1c ≥ 9%), independent of age. 
3) Examine the association between regimen adherence and glycemic control 
in Jordanian adolescents with T1D. 
It was hypothesized that regimen adherence would negatively correlate with 
glycemic control, and adolescents with high adherence scores would have a glycemic 
control ≤ 7.5% as measured by HbA1c, independent of age and disease duration. 
4) Examine the interaction between PA, HRQoL, and regimen adherence in 
the prediction of glycemic control in Jordanian adolescents with T1D.  
It was hypothesized that HRQoL will interact with adherence in the prediction of 
glycemic control with higher scores in both variables predict a glycemic control of ≤ 
7.5% as measured by HbA1c. Also, the HRQoL will interact with PA in the prediction of 
glycemic control with higher scores in both variables predict a glycemic control of ≤ 
7.5% as measured by HbA1c. Finally, there will be no interaction between PA and 
adherence in the prediction of glycemic control. 
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Conceptual Framework 
A conceptual framework for glycemic control in adolescents with T1D was 
developed by the authors to serve as the theoretical model for the study. The framework 
is shown in Figure 1. The framework illustrates glycemic control as an outcome of the 
positive contribution of three main variables: physical activity, health-related quality of 
life, and regimen adherence. Within this framework, the three predictors are interrelated 
and directly influence the glycemic status of adolescents with T1D. When considering 
variables that may influence adolescents’ glycemic control, it is key to acknowledge the 
role of factors within adolescent’s context that may influence the glycemic status such as 
age, gender, disease duration (length of time since diagnosis), and diabetes-related co-
morbidities. These factors can directly or indirectly influence levels of physical activity 
the adolescents perform, their quality of life, and their ability to adhere to their 
therapeutic regimens. 
Methods 
This study utilized a cross-sectional research design.  Self-report questionnaires 
were used to collect data on PA, HRQoL, and adherence from adolescents with T1D. The 
study was conducted at King Abdullah University Hospital (KAUH), a referral tertiary 
hospital located in the northern part of Jordan. The study was completed under the 
supervision of faculty at the University of Texas Health Science Center at Houston, Cizik 
School of Nursing. The study was granted full Institutional Review Board (IRB) approval 
from both institutions (Appendix A & Appendix B). 
Participants 
47 
 
 
 
87 
8
7 
Participants were 12-18-year-old Jordanian adolescents with T1D who visited a 
pediatric endocrinologist at two pediatric diabetes clinics between November 4, 2017, 
and January 11, 2018. Inclusion criteria for the study were as follows: (a) diagnosis of 
T1D >12 months; (b) age 12-18 years (c) have at least 3 measurements of HbA1c; (d) 
free of major mental health diagnosis; (e) able to read, write, and speak Arabic; and (f) 
willing to participate in the study and have parental consent. Subjects suffering from any 
medical condition that interferes with physical activity recommendations were excluded. 
To calculate the sample size, a power analysis was conducted using G*Power 
software (Version 3.1.9.2). For a fixed-model multiple linear regression with three 
predictors, assuming an R2 deviation from zero, a total sample size of 59 was required to 
achieve 80% power with a medium effect size of F2 = 0.20 given the two-sided type I 
error of 5%. Given that a maximum of missing or incomplete data could be 
approximately 25%, the enrollment goal of the study was estimated to recruit 74 total 
subjects. 
A total of 119 participants and their parents were approached and invited to 
participate, and 108 agreed to do so. Of the 108 participants, 74 were eligible and thus 
comprised the sample size in the study. Thirty-four potential subjects were excluded for 
several reasons including missing data (i.e. complete absence of HbA1c data) (n=12), 
being younger than 12-year-old (n=16), have been diagnosed with T1D for less than 1 
year (n=5), and having a medical condition that interferes with physical activity 
recommendations (n=1). The study sample was collected using a nonprobability 
convenience sampling technique. 
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Procedure 
Following IRB approvals, study flyers (Appendix C & Appendix D) were posted 
to announce the study. Prior to recruitment, a support letter from the designated clinic's 
administrations was obtained followed by a brief orientation on the study aim, 
recruitment, and inclusion criteria. While waiting to be seen by their physician, potential 
participants were approached by the researcher and invited to participate in the study in 
the presence of their parents or guardians. If parents and the adolescent agreed, screening 
for eligibility was done by the researcher and a trained nursing student. After informed 
consent was signed by the participant, his/her parents, and a witness (Appendix E & 
Appendix F), the researcher disseminated the study questionnaires. Selected participants 
and their parents were asked to complete the study questionnaires in the waiting room of 
the clinic. The researcher and/or the nursing student remained with the participants to 
answer any questions or comments. Once finished, the researcher and/or the nursing 
student checked that all items had been answered.  
Participants’ medical records were used to obtain the following information: 
HbA1c, height, weight, body mass index, and disease duration. At least one HbA1c value 
over the last year period was obtained from the participants' medical records for study 
inclusion. However, due to the large time difference between the participants in the date 
of the recent HbA1c value, a decision was made that participants with two HbA1c values 
(n=62) were considered in the final analyses using the average of the two values. 
 All participants’ data were kept confidential. Hence, no personal identification 
was recorded and each questionnaires packet was given a unique identification number. 
Participants voluntarily participated in the study with the right to withdraw at any time. 
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The presented findings were derived from participants who completed all questionnaires 
and had at least one HbA1c value. Completed data were entered into a password-
protected statistical software program stored on the researcher’s locked laptop. 
Measures and Instruments 
The Pediatric Quality of Life Inventory 3.0 Diabetes Module (PedsQL-MD). 
The PedsQL-MD Arabic version (Appendix G) is a culturally adapted version of the 
original instrument, The Pediatric Quality of Life Inventory (PedsQL) (Appendix H). The 
PedsQL is a modeled-designed instrument used to measure HRQoL in children and 
adolescents aged 12-18 years (Varni, Burwinkle, Jacobs, Gottschalk, Kaufman, & Jones, 
2003).The PedsQL-MD was designed to measure diabetes-specific HRQoL in children 
and adolescents with T1D aged 12-18years (Varni et al., 2003). The PedsQL-MD 
consists of 28 items with five subscales: Diabetes Symptoms (11 items), Treatment 
Barriers (4 items), Treatment Adherence (7 items), Worry (3 items), and Communication 
(3 items). Respondents rated their responses on a 5-point Likert scale (0 = never a 
problem, 4 = almost always a problem). The scale is available in two forms: the “child 
proxy” and the “parent proxy”. Both proxies were completed by adolescent and/or parent 
respectively. In this study, the two forms are typically similar to the parent proxy 
providing a measure of adolescents’ HRQoL from the view of the parent or caregiver 
(Varni et al., 2003). User agreement with the distribution agency was signed prior using 
the instrument. 
The original version was tested for internal consistency reliability with 
Cronbach’s alpha statistics. The instrument has been previously used in Arabic-speaking 
children with T1D and has demonstrated satisfactory internal consistency reliability 
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(Cronbach’s alpha ˃ .70) (Abdul-Rasoul, AlOtaibi, AlMahdi, & AlKandari, 2012). 
Construct validity of the Arabic version of the instrument was evaluated by examining 
the agreement between subscales in the PedsQL Generic Core Score (GCS) and the 
subscales in the PedsQL-MD using the interclass correlation coefficient (ICC) test. The 
results indicated that the subscales of both instruments sufficiently correlated with their 
total scale (ICC =.81) (Abdul-Rasoul et al., 2012). 
In this study, scoring was performed using the “Scaling and Scoring of the 
Pediatric Quality of Life Inventory™ PedsQL” (Varni, 2014). To compute each score, all 
items were reversed and linearly transformed to a 0-100 scale. The total score was then 
calculated by summing of all items divided by the number of answered items on the total 
scale with higher scores indicating better HRQoL or fewer disease symptoms or 
problems. To account for missing data, the scale score was not computed if more than 
50% of the items were missing. No missing data were detected in this study. 
The International Physical Activity Questionnaire for Adolescents (IPAQ-A). 
The IPAQ-A (Appendix I) is a publicly available instrument used to measure PA in 
adolescents. To measure PA in the study population, the official Arabic short form of the 
IPAQ-A was adopted and used in this study (Appendix J). The instrument has seven 
items and provides information on the PA intensity (vigorous, moderate, walking), 
duration (minutes per session), and frequency (days per week) during the preceding 
week. Two scoring protocols have been proposed by the IPAQ: categorical and 
continuous scoring. Categorical scoring suggests that respondents are to be categorized 
into one of three PA levels; high, moderate, or low using algorithms provided in the 
IPAQ scoring protocol (www.ipaq.ki.se). Continuous scoring suggests that PA levels be 
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expressed as metabolic equivalents (MET) per minute per week. The MET is a 
physiological measure representing the energy expenditure of PA. One MET is defined as 
1 kcal/kg/hour and considered equivalent to the energy consumed by an individual while 
sitting. For the purpose of this study, the continuous scoring protocol was implemented.  
The metabolic equivalents (MET/minute/week) for each participant were 
calculated using the following equation: “MET level x minutes of activity x events per 
week”. All continuous scores for vigorous, moderate and walking were computed and 
expressed as MET-minutes/week using the recommended values for each category as: 
walking PA = 3.3 METs, moderate PA = 4.0 METs and vigorous PA = 8.0 METs. As 
suggested by Ainsworth et al. (2000), the following calculation methods were used and 
yielded four continuous scores:  “(1) Walking MET-minutes/week = 3.3 × walking 
minutes ×  walking days, (2) Moderate MET-minutes/week = 4.0 ×  moderate-intensity 
activity minutes ×  moderate days, (3) Vigorous MET-minutes/week = 8.0 × vigorous-
intensity activity minutes × vigorous-intensity days, (4) Total physical activity MET-
minutes/week = walking + moderate + vigorous MET-minutes/ week scores”. 
Each category of PA (i.e. vigorous, moderate, walking) is represented by two 
questions; one on the duration and one on the frequency. The seventh question in the 
IPAQ is the sitting question, an additional indicator sedentary behavior (sitting) in the last 
preceding week. As per the scoring criteria, the sitting question is not to be considered in 
calculating any of the PA categories. To date, there are no well-accepted thresholds on 
sedentary behaviors to be presented as categorical level. Therefore, the score in this 
question was used as a continuous variable in the subsequent analyses.  According to the 
American College of Sports Medicine and the American Heart Association 
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recommendations, the acceptable range to get the health benefits of PA is 500 to 1,000 
MET-minutes per week (Nelson et al., 2007). 
Data management and analysis for PA were performed using the “Guidelines for 
Data Processing and Analysis of the IPAQ” (2005). The IPAQ was tested for reliability 
and validity in 12 countries during 2000 (Craig et al., 2003). The questionnaire 
demonstrated satisfactory stability of the instrument within the same week with 
Spearman’s correlation coefficients = .80. Results on criterion validity showed moderate 
agreement between the IPAQ short-form and CSA accelerometers (Craig et al., 2003). 
Also, the instrument was tested for validity and reliability in a sample of 51 overweight 
and obese Arabic speaking Tunisian adolescents. Evidence of test-retest reliability with 
2-weeks interval shows high levels of ICC (ICC =.73 - .95) indicating adequate stability 
of the instrument (Regaieg, Charfi, Yaich, Damak, & Abid, 2014). Results on convergent 
validity indicated a strong correlation between the IPAQ-A scores and pedometer step 
counts (r =.66, p <. 001) (Regaieg et al., 2014). 
The Summary of Diabetes Self-Care Activities–Arabic (SDSCA-Arabic). The 
Arabic version of the SDSCA-Arabic (Appendix K) is a culturally validated version from 
the original instrument and has been successfully adapted for patients with type 1 and 
type 2 diabetes mellitus (AlJohani, Kendall & Snider, 2016). The original instrument, 
The Summary of Diabetes Self-Care Activities (Appendix L), has been successfully 
adapted for adolescents aged 12 to 18 years with T1D (Toobert, Hampson & Glasgow, 
2000). The SDSCA-Arabic is an 8-item self-report scale validated to assess the frequency 
of diabetes self-care tasks in the preceding week. The scale has four subscales as follows: 
exercise (2 items); blood-glucose testing (2 items); general diet (2 items), and foot care (2 
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items). The scale measures the number of days (0-7) respondent perform each behavior 
with a total range from 0-56 where higher scores indicate better adherence. The SDSCA-
Arabic was validated on a sample of patients with type 2 diabetes (T2D); however, the 
author recommends that the instrument could be used in T1D patients as it covers the 
same domains of self-management activities recommended for T1D patients (K. A. 
AlJohani, personal communication, November 21, 2016). Psychometric properties of the 
instrument were evaluated in a sample of 243 patients with T2D in Saudi Arabia 
(AlJohani et al., 2016). Evidence of reliability includes Cronbach’s alpha of .76, 
indicating internal consistency reliability, and test-retest (r =.912, p < .001) indicating 
adequate stability of the instrument (AlJohani et al., 2016). 
Glycemic Control. Glycemic control was measured by HbA1c levels. Values 
were obtained retrospectively from the participants’ medical records at time of participant 
clinic visit using a data sheet developed for the purpose of this study (Appendix M). For 
greater stability and consistency across the sample, participants’ HbA1c values were 
averaged across the most recent two values over the preceding year. The ADA (2017) 
recommends HbA1c levels for adolescents to be below 7.5%. High HbA1c levels were 
indicated as poor glycemic control. 
Demographic and Clinical Information Questionnaire. Participants’ 
demographic and clinical information were collected using a structured questionnaire 
developed for the purpose of the study and completed by the adolescents’ and/or their 
parents (Appendix N & Appendix O). Data were collected about participants’ age, 
gender, education level, parents marital status, parenthood, father education, father 
employment, mother education, mother employment, health insurance, disease duration, 
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age at diagnosis, family history of diabetes, BMI, diabetes-related co-morbidities, mode 
of insulin delivery, number of daily injections, frequency of daily blood glucose 
measurement, number of hospitalizations due to diabetes last year, and episodes of 
reported hypoglycemia last month.  
Statistical Analysis 
Statistical analyses were performed by the researcher using the Statistical Package 
for the Social Sciences (SPSS-IBM) computer software, version 25.0 (SPSS Inc., 
Chicago, IL, USA). Initially, univariate outliers and violation of statistical assumptions 
were checked prior to analysis. To assess for univariate outliers, all variables were 
standardized and the Z-scores were computed. From a statistical point of view, the 
empirical rule indicates that 99.7% of the data must fall within three standard deviations 
from the mean (Shiffler, 1988). Therefore, a decision was made that any Z-score less than 
-3 or greater than 3 is considered as an outlier and removed from the analyses. Further, 
visualization of the outliers was done through computing the boxplot for each variable.  
Univariate normality was assessed with skewness and kurtosis. Variable transformation 
was considered if skewness or kurtosis values greater than 1.5. In the regression analysis, 
multicollinearity was examined with the Variance Inflation Factor (VIF), a statistical test 
that measures the effect of collinearity among the regression variables. Values of VIF that 
exceeded 10 were regarded as indication of multicollinearity. Also, homoscedasticity and 
linearity between the dependent and independent variables were assessed through 
visualization of the residuals scatterplot for each regression model. 
Descriptive statistics were reported for the total sample (N=74).  Mean, standard 
deviation (SD), 95% confidence interval (IC) for mean, median, and range were reported 
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for continuous variables. As well, frequency and percentage were reported for categorical 
variables. For greater stability, each participant’s HbA1c data were reviewed to verify at 
least two values in the preceding year. If this criterion was not met, the participant was 
excluded from the correlation and regression analyses. The average of two values was 
then calculated and used as an indicator of glycemic control. Independent samples 
Student’s t-tests were used to examine the mean difference in total HRQoL scores, total 
PA scores, total regimen adherence scores, and sedentary PA between males and females.  
The strength of correlation between the dependent variable (HbA1c) and the three 
main independent variables (PA, HRQoL, regimen adherence) was examined using 
Pearson product-moment correlation coefficient at two-tailed significance level. The 
strength of correlation was also examined between demographic and clinical variables 
and HbA1c using Pearson product-moment correlation coefficient for normally 
distributed continuous variables (age, disease duration, BMI), and Spearman’s Rank-
Order correlation coefficient for categorical, non-normally distributed variables 
(education level, father education, mother education, father employment, mother 
employment).  
A multiple linear regression model was performed with averaged HbA1c as the 
dependent variable, and PA, HRQoL, and regimen adherence as the independent 
variables. According to Aiken & West (1991), all analyses were performed on the 
standardized z-scores. The first model included only the main effects of the three 
predictors. A second model was run and adjusted for age and disease duration. To test the 
effect of interaction, a third model was conducted including the main effects of the three 
predictors (PA HRQoL, regimen adherence), the adjusted variables (age, disease 
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duration), as well as the interaction between PA and HRQoL, the interaction between PA 
and regimen adherence, and the interaction between HRQoL and regimen adherence. 
Variance Inflation Factor was implied to examine multicollinearity between the 
dependent variable and independent variables in each model. The significant change in F-
test (˂.05) and the model R2were used in model selection and to assess the overall 
goodness of fit for each model. A p value of ˂.05 was used as an indicator of statistical 
significance in all of the analyses. 
Results 
Demographics and Clinical Characteristics 
Of the 119 participants/parents approached, 108 (90.7%) agreed to participate in 
the study. Of those agreed, 74 (68.5%) were eligible and thus comprised the sample size 
in the study. Results on participants’ demographics and clinical characteristics included 
data from the total sample (N=74). Summary of participants’ demographics are shown in 
Table 1. Data are presented in mean (±SD).The mean age of the participants was 14.15 (± 
1.55) years. The sample was primarily female (61%), 6th -10th school grader (79.7%), 
and living with both parents (94.6%). The parents were married in most of the cases 
(95.9%) and divorced in 4.1%. Thirty-eight percent of fathers and 43.2% of mothers 
reported education at college or university level. More than half the parents (62.1% of the 
fathers and 56.7% of the mothers) reported education at high school or less. Full-time 
employment was reported by 68.9% of the fathers and 10.8% of the mothers. The 
majority of the mothers (81.1%) were unemployed, whereas only 6.8% of fathers 
reported unemployment status. 
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Clinical characteristics of participants are presented in Table 2. All participants 
reported receiving insulin treatment with daily insulin injections with a mean of 2.76 (± 
.65) injections per day across the entire sample. Mean age at diabetes onset was 8.99 (± 
1.97) years and mean disease duration since diagnosis with T1D was 5.15 (± 2.44) years. 
The frequency of blood glucose measurement was reported at a mean of 2.51 (± .78) 
measurements per day. 
Hospitalization due to diabetes in the preceding year was also reported with a 
mean of 1.38 (± 1.10) admissions in the entire sample.  The median number of 
hypoglycemic episodes in the preceding month was 2.6(range = 6) episodes. According 
to the calculated BMI, 15 (20.3%) participants were underweight, 36 (48.6%) were 
normal weight, and 23 (31.1%) were either overweight or obese. The overall mean of 
participants’ BMI was 2.47 (± 1.68). 
Descriptive statistics of glycemic control, PA, HRQoL, and regimen adherence 
are presented in Table 3. Overall, the mean percentage of HbA1c was 10.6 (± 2.81) 
indicating poor glycemic control among the total sample with slightly higher values in 
males (10.47 ± 2.68) than females (9.80 ± 2.89). Stratification of participants according 
to the HbA1c was done where participants with values of ≤ 7.5 were categorized as 
having good glycemic control and those with values ˃ 7.5% were categorized as being in 
poor glycemic control. The results showed that only 11 (14.7%) participants 
demonstrated good glycemic control (HbA1c ≤ 7.5%) with no statistically significant 
difference in age and disease duration compared with participants with poor glycemic 
control. Participants with poor control had a statistically significant lower mean PA of 
58 
 
 
 
87 
8
7 
MET-minutes/week (3531.9 ± 1356.75 vs. 1619.81 ± 1481.95, p <.001) compared with 
good control. 
The total sample was found to demonstrate below-average HRQoL with a mean 
total score of 47.70 (± 10.32).  Female adolescents with T1D reported slightly higher 
total HRQoL (49.55 ± 10.50) than males (44.38 ± 9.52). Among the entire sample, the 
HRQoL scores were lower for diabetes symptoms (38.31 ± 20.37) and worry (25.62 ± 
25.28) domains, and higher for communication (64.92 ± 23.11) domain. 
Participants were within the acceptable range of PA with a mean of 1946.3 
(±1321.91) MET-minutes per week for males and 1848.8 (±1760.82) MET-minutes per 
week for females (Nelson et al., 2007). Only 23 (31%) participants (10 males and 13 
females) reported performing vigorous PA in the last 7 days with means of 2496 and 
1115 MET-minutes per week respectively, and 67 (90.54%) reported performing 
moderate PA in the last 7 days with means of 831 and 674 MET-minutes per week 
respectively. The mean MET-minutes per week of walking was 937.42 (± 697.58) in 
males and 954.36 (± 880.36) in females. Regarding regimen adherence, the mean total 
score was 38.09.36 (± 8.86) for the entire sample with slightly higher in males than 
females (39.44 ± 7.84 vs. 37.22 ± 9.16). 
Bivariate and Multivariate Analyses 
All univariate and multivariate analyses were performed on the 62 participants 
who met the criterion of having at least two HbA1c values. To account for normality, all 
analyses were performed on the standardized z-scores. Outliers were detected and 
removed (n=2 in PA scores) from the analyses.  
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Independent samples Student’s t-tests were performed to compare the means 
between males and females on HbA1c, HRQoL, PA, regimen adherence, and sedentary 
PA. The analysis showed that there was no statistically significant mean difference 
between males and females in HbA1c, HRQoL, PA, regimen adherence, and sedentary 
PA (Table 4). 
To determine the relationships between HRQoL, PA, regimen adherence, clinical 
characteristics, and glycemic control, a Pearson product-moment correlation coefficient 
analysis was performed. The data were assessed for violation of statistical assumptions 
prior to analysis. Each variable was measured on a continuous scale, significant outliers 
were detected and removed, and normality was ascertained by using the standardized z-
scores. The results are presented in Table 5. The analysis indicated a moderate, inverse 
correlation between PA and glycemic control as measured by HbA1c, which was 
statistically significant (r = -.328, n = 60, p = .010). Correspondingly, there was a 
moderate, positive correlation between sedentary PA and glycemic control as measured 
by HbA1c, which was statistically significant (r = .337, n = 60, p = .009). However, the 
analysis indicated a marginally moderate, inverse correlation between regimen adherence 
and HbA1c, which was statistically significant (r = -.299, n = 62, p = .018), this 
association did not appear in the subsequent multiple regression analyses. Further, there 
was no statistically significant association between glycemic control and HRQoL. There 
was also no statistically significant association between glycemic control and any of the 
clinical characteristics (including age), except for number of hypoglycemic episodes 
which was moderate and negative (r= -.371, n = 62, p = .003). 
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A Spearman's Rank-Order correlation analysis was conducted to determine the 
relationship between glycemic control and categorical, non-normally distributed variables 
including education level, father education, mother education, father employment, and 
mother employment. There was no any statistically significant correlation between 
glycemic control and any of the tested variables (Table 6). 
To determine if HRQoL, PA, and regimen adherence predicts adolescents’ 
glycemic control while adjusting for age and disease duration, three multiple regression 
analyses were conducted.  The data were assessed for violation of statistical assumptions 
prior to analysis. Significant outliers were detected and removed (n=2 in PA scores). 
Assumptions on homoscedasticity and multicollinearity were assessed through plotting 
the studentized residuals against the unstandardized predicted values. To account for 
normality, regression analyses were conducted using the standardized Z-scores. The three 
models are presented in Table 7.  In the first unadjusted, main-effects model, HbA1c was 
regressed with HRQoL, PA, and regimen adherence as predictors. The model was 
statistically significant and explained 22.8% of the variance in glycemic control (F(3, 
56)= 5.523, p <.01, R2 = .228). It was found that PA significantly predicted glycemic 
control (β = -.367, p < .01) as adherence did (β = -.409, p < .01). The regression 
coefficient associated with PA suggesting that for each one standardized unit increase in 
PA is associated with a .367 unite decrease in HbA1c. Also, an increase of one 
standardized unite in regimen adherence is associated with a .409 unite decrease in 
HbA1c. After adjustment for age and disease duration in the second model, PA and 
regimen adherence remained statistically significantly associated with the prediction of 
glycemic control and the magnitude of association was nearly the same for PA (β = -.360, 
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p <.01) and increased by 6.6% for regimen adherence (β = -.475, p <.01). It is suggested 
that a one unit increase in PA is associated with a .36 unite decrease in HbA1c holding 
age and disease duration constant. Interestingly, disease duration appeared to be 
significantly predictive of glycemic control (β= .444, p <.01) suggesting that each 
additional year in disease duration is associated with a .444 unit increase in HbA1c 
holding other variables constant in the model. The adjusted model was statistically 
significant and increased the amount of explained variance by 9.4% (F(2, 54)= 3.726, p 
<.05, R2 = .322). 
The final regression model was run including the unadjusted main-effects 
variables, the adjusted variables (age and disease duration), and the interaction terms 
between PA and HRQoL, PA and regimen adherence, and HRQoL and regimen 
adherence. The interaction model improved significantly and explained 43.4% of the 
variance in HbA1c (F(8, 51)= 4.883, p < .05, R2 = .434). Both PA and regimen adherence 
remained statistically significant in the interaction model (β = -.488, p <.001, β = -.373, p 
<.01 respectively). None of the interaction terms was statistically significant except for 
the interaction between PA and regimen adherence (β = -.304, p <.05).  
As described by Aiken & West (1991); when an interaction effect is present, the 
impact of one predictor depends on the level of the other predictor. In order to interpret 
the interaction effect in the regression model, regimen adherence was transformed into 
three categories as low (scores between 0-30), moderate (scores between 31-45), and high 
(scores between 46-56), then a scatterplot with a regression fit line was generated with 
PA as a combined variable and glycemic control as a dependent variable. The interaction 
between PA and regimen adherence is graphed using regression lines in Figure 2. 
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Correlations were calculated by taking the square root of R2 linear values. As shown on 
the graph, the correlation between PA and HbA1c is .62 for adolescents with high 
regimen adherence level, .57 for adolescents with moderate regimen adherence level, and 
.16 for adolescents with low regimen adherence level. Therefore, the correlation between 
PA and glycemic control depends highly on the level of regimen adherence or arguably, 
adherence acts as a buffer in the correlation between PA and glycemic control.  
Discussion 
The cross-sectional study assessed the associations between PA, HRQoL, regimen 
adherence, and glycemic control in adolescents with T1D in Jordan. Also, the mean 
differences between male and female adolescents in reported HRQoL, PA, regimen 
adherence and HbA1C were examined. Finally, the prediction of the HbA1c level by PA, 
HRQoL and regimen adherence levels and the interactions between the variables was 
explored. 
Overall, only 14.8% of the participants in the current study demonstrated normal 
glycemic control (HbA1c ≤7.5%).  This is in line with the data that few of the adolescents 
with T1D achieve the recommended target (Livingstone et al., 2012; Mohammad, 
Farghaly, Metwalley, Monazea, & Abd El-Hafeez, 2012). Further, our results indicated 
that age was not associated with glycemic control. This contradicts the results supported 
by several studies indicating that glycemic control decreases with advancement in age 
(Vanelli et al., 2005; Aljabri & Bokharim 2013; Clements et al., 2014). Several 
explanations might be that the current sample was small, considering limited age range 
(12-18), and the majority of the participants (79.9%) were aged between 12 and 15 years. 
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It is noticeable to report that disease duration was a significant predictor of 
glycemic control. Adolescents with longer disease duration since age of onset exhibited 
higher levels of HbA1c compared with adolescents with shorter disease duration which is 
supported by other research findings (Mohammad et al., 2012; Esdonk et al., 2017). From 
a physiological point of view, this could be explained due to the progressive dysfunction 
of pancreatic beta cells leading to increase insulin resistance and uncontrolled blood 
glucose. However, longer disease duration may support decreased satisfaction, socio-
emotional disadvantage, poor illness perception, which all together may interrupt the 
adherence and subsequently, glycemic control.  
The primary finding was as hypothesized that the amount of PA measured by 
MET-minutes per week inversely correlates with HbA1c level, suggesting that by 
increasing the amount of performed PA, a moderate decrease in HbA1c percentage is 
expected. This finding was also supported by the results in the regression analyses where 
improvement in HbA1c was predicted by level of PA as measured by MET-minutes per 
week. This is consistent with previous studies on the effect of PA on glycemic control in 
pediatric population with T1D (Gusso, Pinto, Baldi, Robinson, Cutfield, & Hofman, 
2012; Miculis, De Campos & da Silva Boguszweski, 2015; Nguyen et al., 2015; Carabott 
Pawley, Damato, Torpiano, & Caro, 2016) and with what was suggested by two recent 
meta-analyses that physically active adolescents with T1D demonstrated improved 
glycemic control (Tonoli et al., 2012; Quirk et al., 2014). Despite that, several studies did 
not support the beneficial effects of PA on glycemic control (Aman et al., 2009; Galler et 
al., 2011; Kennedy et al., 2013). These differences might be explained by several reasons 
including varied research designs, small sample size, and type, duration, and frequency of 
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PA investigated across the studies. Therefore, it is suggested that the benefits are mostly 
dependent on the type, intensity, duration, and frequency of the activity.  
In the Arab world, there are few studies investigated the effect of PA on glycemic 
control in adolescents with T1D. A recent study conducted in Saudi Arabia in 2015 
aimed to correlate PA with glycemic control in children with T1D. The study findings 
were in line with our findings where lower HbA1c levels were found in patients with 
more frequent PA (Al-Agha, Alrefaie, Elhameed, Ahmad, & El-Derwi, 2015). However, 
participants in the current study were within the acceptable range of PA, about one-third 
of them only reported performing vigorous PA, and regular habitual PA of light to 
moderate intensity appeared to be the dominant form and induced the observed positive 
effect on glycemic control. This might be explained by several reasons. Where fear of 
hypoglycemia during and after exercise is suggested to be the likely main barrier to PA in 
children and adolescents with T1D (McGill & Levitsky, 2016; Roberts, & Taplin, 2015), 
the cultural components and family structure in Arab countries may also contribute to the 
situation. This statement is strongly supported by a recent large cross-cultural study 
conducted to explore the personal, social, and environmental barriers to PA among 
adolescents in seven Arab countries (Jordan, Syria, United Arab Emirates, Palestine, 
Libya, Kuwait, Algeria) (Musaiger et al., 2013). The main barriers to PA in the study 
were low social support, lack of motivation to do PA, and lack of time to participate in 
PA. These barriers were faced more by females than males within each country and 
across all countries (Musaiger et al., 2013). Although fear of severe hypoglycemia is a 
strong and evident factor to consider, strategies to overcome barriers to PA among Arab 
adolescents need to take into consideration the social support from parents, teacher, and 
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peers, socio-cultural factors, motivational factors, and accessibility of PA facilities in and 
out schools. In respect to the study findings, there is lack of PA type-specific analysis due 
to the used scoring criteria, and PA was measured by the level of energy expenditure 
which is multi-factorial and could not be determined by use of a self-report questionnaire. 
Patient adherence is important for effective outcomes of any medical treatment. 
Failure to adhere with diabetes treatment regimens can worsen glycemic control that can 
lead to negative clinical outcomes (Borus & Laffel, 2010). In the current study, there was 
an inverse correlation between regimen adherence and glycemic control, suggesting that 
by increasing level of regimen adherence, a moderate decrease in HbA1c percentage is 
expected. This finding also appeared in the regression analysis where improvement in 
HbA1c was predicted by level of regimen adherence. This is in line with the literature 
where several studies suggested that regimen adherence is a core component in 
improving glycemic control in adolescents with T1D independent of age and disease 
duration (Ellis, Naar-King, Chen, Moltz, Cunningham, & Idalski-Carcone, 2012; Nansel, 
Iannotti & Liu, 2012; Holmes, Chen, Mackey, Grey & Streisand, 2014). Moreover, the 
meta-analysis by Hood and colleagues (2009), confirmed that as regimen adherence 
increases, HbA1c decreases with a mean effect size of -.32 at 95%CI across 21 studies 
(Hood et al., 2009).  
Further, the combination of regimen adherence and PA was found to be predictive 
of better glycemic control independent of age and disease duration effects. This reflects 
the ADA (2017) and Healthy People 2020 recommendations for improving glycemic 
control through a combination of daily PA and adherence to treatment components 
(Office of Disease Prevention and Health Promotion, 2016, ADA, 2017). It is also highly 
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debatable that deterioration in glycemic control in adolescents with T1D is strongly 
related to the hormonal and physiological changes occurred at puberty (Chowdhury, 
2015). However, being physically active and more adherent to the recommended 
regimens may positively advocate for better glycemic control in the context of our study. 
Health-related quality of life has increasingly been considered as an essential 
component of chronic disease treatment. Also, more emphasis has been given to 
assessing, monitoring, and studying the HRQoL of adolescents with T1D (Abdul-Rasoul 
et al., 2013). The current study found that HRQoL was below average in the entire 
sample which is consistent with what is reported by Al-Akour et al. (2010) in a sample of 
145 Jordanian adolescents with T1D when HRQoL was significantly reported as low (Al-
Akour et al., 2010). Moreover, this is supported by several previous studies (Kalyva, 
Malakonaki, Eiser & Mamoulakis, 2011; Al-Hayek et al., 2014; Murillo et al., 2017). 
This might be explained by that the presence of T1D at this age increases the demand for 
the adolescents and their families to manage the disease and maintain glycemic control. 
In addition to that, and taking into consideration that the sample was primarily females, 
the nature of culture may play a major role in shaping this low level of HRQoL where 
adolescents especially females have limited accessibility to treatment components.  
Further, the Pearson’s correlation analysis supported by the regression analyses 
showed no association between reported HRQoL and glycemic control, which is 
consistent with some previous studies (Bas et al., 2011; Caferoğlu, İnanç, Hatipoğlu & 
Kurtoğlu, 2016). On the other hand, several studies reported an inverse association 
between HRQoL and HbA1c (Tahirović, Toromanović, Tahirović, Begić & Varni, 2012; 
Samardzic, Tahirovic, Popovic & Popovic-Samardzic, 2016; Hassan, Musa, Hai, Fathy & 
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Ibrahim, 2017). Some potential reasons that might explain our results include the low 
sample size with lack of a healthy control comparison. Moreover, inconsistency was 
identified in measuring instruments used in the mentioned studies, where some studies 
assessed HRQoL using the generic HRQoL scale, while this study used a diabetes-
specific HRQoL scale. Further, the scale asks respondents to report their HRQoL for the 
preceding month which could be considered as a source of recall bias.  
Strengths and Limitations 
Despite the findings, this study has various strengths and limitations. The main 
strength of the current study is the fact that that it is the first study conducted in Jordan to 
assess PA and regimen adherence with relation to glycemic control in adolescents with 
T1D. Moreover, it gives foundational data on the levels of PA and regimen adherence 
and their associations with glycemic control. Further, the bivariate and multivariate 
analyses were conducted using the averaged HbA1c of the recently available values, 
which decreases the variability between subjects and ensures greater stability of the 
results.  
In contrast, several limitations were noted. The utilization of cross-sectional 
design limits the ability to draw causal-effect relationship. However, there were 
significant associations between PA, regimen adherence and glycemic control, 
temporality remains unclear whether being physically active promotes glycemic control 
or having good glycemic control motivates adolescents to engage in daily physical 
activities.  Furthermore, the sample size was small and recruitment was done using a non-
probability convenience sampling technique yielding a non-representative sample of the 
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study population. Therefore, the generalizability of the findings is limited and future 
research is needed on larger samples using random selection techniques. 
Additional consideration is that the data were largely based on self-report. 
Although the study used valid and reliable culturally-adapted instruments, self-report 
instruments are inherently susceptible to information bias and recall bias with a chance of 
overestimation of the studied variables. Moreover, the proposed study was to include 
participants with at least three HbA1c values, several participants had done their 
glycemic measurements outside the study setting, and the researchers did not have access 
to outside medical records. Finally, conducting several statistical analyses may increase 
type 1 error; however, our results were somehow consistent entirely and in line with the 
empirical findings from previous studies on adolescents with T1D. 
Conclusion and Recommendations 
Based on the study findings, only 14.8% of the participants demonstrated normal 
glycemic control (HbA1c ≤7.5%). There were no significant gender differences in 
glycemic control, PA, HRQoL, and regimen adherence. Jordanian adolescents with T1D 
aged between 12 and 18 years old were within the acceptable range of PA (1946.3 ± 
1321.91) MET-minutes per week, found to demonstrate below-average HRQoL (47.70 ± 
10.32), and with moderate regimen adherence levels (38.09.36 ± 8.86). It was found that 
glycemic control measured by HbA1c was significantly positively correlated with disease 
duration and inversely with PA and regimen adherence. Participants with poor control 
had a statistically significant lower mean PA of MET-minutes/week, lowered regimen 
adherence levels, and longer disease duration compared with better glycemic control. 
There was no significant association between glycemic control and HRQoL. The findings 
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also showed that PA, regimen adherence, and disease duration are significant predictors 
of glycemic control independent of age and HRQoL. However, the combination of 
increase in levels of PA and regimen adherence would yield a significant reduction of 
HbA1C independent of disease duration, HRQoL, and age. 
Although there were some limitations, the study provides valuable data for 
glycemic control, PA, HRQoL, and regimen adherence among adolescents with T1D in 
Jordan. Also, the results highlight the importance of PA, HRQoL, and adherence in the 
management of T1D in adolescents. Caregivers at different levels (home, hospitals, and 
schools) are advised to consider the importance of factors associated with the glycemic 
control that would help with the integration of more effective measures to prevent 
diabetes-associated complications. Finally, further research is needed to build on this 
study and provide more information on psychosocial and cultural factors that impact 
glycemic control and subsequently the quality of life in this population.  
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Table 1 
Demographic Characteristics of the Study Population (N=74) 
 
Characteristic 
 
Frequency 
 
Percentage 
Gender   
Male 29 39% 
Female 45 61% 
 
Living with Both Parents   
Yes 70 94.6% 
No 4 5.4% 
 
Parent Marital Status   
Yes 71 95.9% 
No 
 
3 4.1% 
Father Education   
Less Than High School 14 18.9% 
High School 32 43.2% 
College Degree 13 17.6% 
Bachelor Degree 14 18.9% 
Master Degree 0 0% 
Doctoral Degree 
 
1 1.4% 
Mother Education   
Less Than High School 14 18.9% 
High School 28 37.8% 
College Degree 22 29.7% 
Bachelor Degree 10 13.5% 
Master Degree 0 0% 
Doctoral Degree 
 
0 0% 
Father Employment   
Unemployed 5 6.8% 
Part-time 18 24.3% 
Full-time 
 
51 68.9% 
Mother Employment   
Unemployed 60 81.1% 
Part-time 6 8.1% 
Full-time 
 
8 10.8% 
Age (M± SD) 14.15 ± 1.55  
Note. M = mean; SD = standard deviation. 
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Table 2 
Clinical Characteristics of the Study Population (N=74) 
 
 
Variable 
 
 
Mean(SD) 
 
 
Median 
 
 
Range 
 
95% CI 
LL UL 
Disease Duration (Year) 
 
5.15 (2.44) 5 9 4.58 5.71 
Age at Diagnosis (Year) 
 
8.99 (1.97) 9 10 8.54 9.45 
BMI (kg/m2) 22.0(4.47) 21.5 23.8 20.96 23.04 
      
Daily Insulin Injections 
 
2.76 (.65) 3 3 2.60 2.91 
Daily Glucose Measurements  
 
2.51 (.78) 3 5 2.33 2.69 
Diabetes Hospitalizations 1.38 (1.10) 1 4 1.12 1.63 
 
Episodes of Hypoglycemia 2.47 (1.68) 2.5 6 2.08 2.86 
Note. BMI = body mass index; SD = standard deviation; CI = confidence interval; LL = lower limit; UP = 
upper limit. 
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Table 3 
Descriptive Statistics of HbA1C, PA, HRQoL, and Regimen Adherence (N=74) 
 
 
 
Gender 
  
 
HbA1C 
  
HRQoL Dimensions 
  
PA (MET-min/week) 
  
Adherence 
  I II III IV V Total  V M W Total  Total 
Male Mean 10.47  33.38 58.97 57.39 20.68 63.96 44.83  2496 831.07 937.24 1946.30  39.44 
 SD 2.68  18.20 9.61 10.13 26.22 24.98 9.52  3238 710.68 697.58 1321.91  7.84 
 n 
 
29  29 29 29 29 29 29  10 28 29 27  29 
Female Mean 9.80  41.50 60.00 59.80 28.81 65.55 49.55  1115 684.49 954.36 1848.82  37.22 
 SD 2.89  21.24 12.59 12.74 24.42 22.09 10.50  1492 589.63 880.36 1760.82  9.16 
 n 
 
45  45 45 45 45 45 45  13 39 44 45  45 
Total Mean 10.06  38.31 59.60 58.86 25.62 64.92 47.70  1715 745.75 947.56 1885.38  38.09 
 SD 2.81  20.37 11.46 11.77 25.28 23.11 10.32  2448 641.95 807.57 1601.13  8.68 
 n 74  74 74 74 74 74 74  23 67 73 72  74 
Note. HbA1C = glycated hemoglobin; HRQoL = health-related quality of life; PA = physical activity; MET = metabolic equivalents; HRQoL dimension I= 
diabetes symptoms; dimension II= treatment problems; dimension III = treatment adherence; dimension IV = worry; dimension V = communication; PA-V= 
vigorous physical activity; M-PA = moderate physical activity; W-PA = walking physical activity; SD = standard deviation. 
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Table 4 
Independent Samples Student’s t-tests (N=62) 
 
Variable 
 
Gender 
 
n 
 
Mean 
 
SD 
 
∆ Mean 
 
t 
 
p 
95% CI 
LL UL 
Averaged HbA1C (%) Male 23 9.9 2.47 .163 2.38 .813 -1.20 1.53 
 Female 39 9.7 2.67      
          
HRQoL Male 23 46.5 9.48 -3.23 -1.2 .227 -8.53 2.07 
 Female 39 49.7 10.42      
          
PA (MET-min/week) Male 21 2110.6 1401.3 223.53 .479 .633 -708.97        1156.05 
 Female 39 1887.12 1867.6      
          
Regimen Adherence Male 23 38.47 8.34 1.78 .762 .449 -2.90                6.47 
 Female 39 36.69 9.22      
Note.HbA1C = glycated hemoglobin; HRQoL = health-related quality of life; PA = physical activity; MET = metabolic equivalents; n = number of subjects; SD 
= standard deviation; ∆ Mean = mean difference; t = t statistics; p = significance value; CI = confidence interval; LL = lower limit; UP = upper limit
90 
 
 
 
 
Table 5 
Pearson’s Correlations between Glycemic Control and Measured Variables (N=62) 
 
 
Variable 
 
HbA1C 
 
 
p r 
Age .12 .354 
Disease Duration .24 .060 
BMI -.013 .923 
Daily Insulin Injections .044 .733 
Daily Glucose 
Measurements 
-.216 .091 
Episodes of Hypoglycemia -.371 .003** 
HRQoL .073 .570 
PA(MET-min/week) -.328 .010* 
Regimen Adherence -.299 .018* 
Sedentary PA .337 .009** 
Note.HbA1C = glycated hemoglobin; BMI = body mass index; HRQoL = health-related quality of life; PA 
= physical activity; MET = metabolic equivalents; r = Pearson’s correlation; p = significance value. 
*p< .05. **p< .01.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
91 
 
 
 
 
Table 6 
Spearman’s rank-order Correlations between Glycemic Control and Categorical 
Variables (N=62) 
 
 
Variable 
 
HbA1C 
 
 
p rs 
Participant’s Education .064 .622 
Father Education -.159 .216 
Mother Education -.097 .454 
Father Employment -.091 .480 
Mother Employment .005 .967 
Note.HbA1C = glycated hemoglobin; rs = spearman’s correlations; p = significance value  
Correlation is significant at the 0.05 level (2-tailed). 
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Table 7 
Unadjusted, Adjusted, and Interaction Regression Models Predicting Glycemic Control  
 
Predictor 
 
Unstandardized B 
 
SE B 
 
p 
 
VIF 
 
∆ R2 
 
∆F 
 
p (∆F) 
Model 1 (Unadjusted) 
 
    
.228 5.52 .002** 
HRQoL -.163 .140 .249 
    
PA -.367 .120 .003** 
    
Regiment Adherence -.409 .140 .005** 
    
        
Model 2 (Adjusted) 
    
.322 3.72 .031* 
Age -.266 .156 .093 1.83 
   
Disease Duration .444 .163 .009 1.97 
   
HRQoL -.023 .143 .871 1.60 
   
PA -.360 .117 .003** 1.05 
   
Regimen Adherence -.475 .136 .001** 1.43 
   
        
Model 3 (Interaction) 
    
.434 3.35 .026* 
Age -.317 .161 .055 2.22 
   
Disease Duration .411 .158 .012* 2.10 
   
HRQoL .003 .149 .984 1.28 
   
PA -.488 .121 .000*** 1.98 
   
Regimen Adherence -.373 .135 .008** 1.61 
   
PA × HRQoL .025 .173 .885 1.73 
   
PA × Adherence -.304 .133 .027* 1.80 
   
HRQoL × Adherence -.266 .157 .096 1.39 
   
Note. Dependent variable is glycemic control measured by glycated hemoglobin (HbA1C). 
SE B = standard error of beta; VIF= variance inflation factor; HRQoL = health-related quality of life; PA = 
physical. 
Model 1 includes only the main-effects on the three predictors (HRQoL, PA, Regimen adherence). 
Model 2 includes the main-effects on the three predictors (HRQoL, PA, Regimen adherence) adjusted for 
age and disease duration. 
Model 3 includes the main-effects on the three predictors adjusted for age and disease duration, and the 
interaction terms between PA and HRQoL, PA and regimen adherence, and HRQoL and regimen 
adherence. 
All regression models were conducted on the standardized scores. 
*p < .05. **p< .01. ***p< .001.  
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Figure 1. A conceptual framework for glycemic control in adolescents with T1D. 
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Figure 2.  Scatterplot of the interaction between physical activity and regimen adherence in predicting 
glycemic control. The bold line represents the association between physical activity and glycemic control in 
participants with low adherence levels. The light-dotted line represents the association between physical 
activity and glycemic control in participants with moderate adherence levels. The dark-dotted line 
represents the association between physical activity and glycemic control in participants with high 
adherence levels. 
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Abstract 
Background: Type 1 diabetes is an autoimmune disease affecting children and 
adolescents and considered as the second most common chronic condition in this 
population. Generally, patients with diabetes are advised to adhere to several self-
management behaviors to prevent short and long-term associated complications.  
Accurate assessment of patient adherence is important for effective outcomes of medical 
treatment. As in case of diabetes, the availability of accurate information on self-care 
activities level alongside with measures of glycemic control allow health care providers 
to monitor patients’ behavior and adjust their plans and recommendations to enhance 
diabetes control The aim of this study is to translate the ADQ-C-C version of the ADQ 
into Arabic and examine the psychometric properties of the Arabic version in Jordanian 
adolescents with T1D. Methods: The psychometric protocol presented in this paper is 
divided into two phases: (a) Arabic translation of the ADQ-C-C; (b) psychometric testing 
of the translated version in Jordanian adolescents aged 12 to18 years with T1D. The 
translation will be guided by the guidelines of translation and cross-cultural adaptation of 
self-report measures recommended by Beaton, Bombardier, Guillemin, and Ferraz 
(2000). A cross-sectional study design will be employed to psychometrically assess the 
ADQ-C-C-Arabic a sample of 500 Jordanian adolescents aged 12 to18 years with T1D. 
The study will test the final adopted versions for internal consistency reliability using 
Cronbach’s alpha measure, test-retest reliability using The Pearson product moment 
correlation coefficient, and construct validity using both confirmatory and exploratory 
factor analyses. The Item Response Theory of measurement will be utilized to evaluate 
the psychometric performance of the Arabic version of the ADQ-C-C using the Graded 
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Response Model of fitness. Discussion: Since there has been little research on diabetes 
self-care activities in Jordanian adolescents with T1D and the search of literature showed 
no available Arabic version instrument that has been used to measure regimen adherence, 
the outcome of this study will produce a valid and reliable Arabic version of the source 
questionnaire (ADQ) that could be used to measure regimen adherence in Arabic 
speaking adolescents with T1D.  
Keywords: psychometrics, validity, reliability, item response theory, type 1 
diabetes, adolescents, adherence, cultural-adaptation. 
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Background 
Type 1 diabetes is an autoimmune disease affecting children and adolescents and 
considered as the second most common chronic condition in this population. [1] Type 1 
diabetes is a serious condition associated with significant morbidity and mortality due to 
both acute and long-term complications. [2] Generally, patients with diabetes are advised 
to adhere to several self-management behaviors to prevent short and long-term 
complications. Disease management is more challenging for patients with T1D as they 
are required to follow a lifelong therapy. [3] The recommended regimen for T1D includes 
frequent checking of blood glucose levels, daily administration of insulin injections or 
use of an insulin pump, regulating carbohydrate intake, and performing daily physical 
exercises. [4] Accurate assessment of patient adherence is important for effective 
outcomes of treatment. As in case of diabetes, the availability of accurate information on 
self-care activities level with measures of glycemic control allow health care providers to 
monitor patients’ behavior and adjust recommendations that enhance diabetes control. [5] 
However, there has been little research on diabetes self-care activities in Jordanian 
adolescents with T1D and the search of the literature showed no available Arabic version 
instrument that has been used to measure self-care adherence. Therefore, the aim of this 
study is to translate the Adherence in Diabetes Questionnaire (ADQ) [6] into Arabic and 
psychometrically test it in Jordanian adolescents aged 12 to18 years with T1D. 
Adherence is a concept widely used to reflect one’s ability to follow healthcare 
advice and achieve effective clinical outcomes. The term adherence originated from 
behavioral sciences and was adopted to be used instead of compliance. [7] The World 
Health Organization defined adherence as “the extent to which a person’s behavior 
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(taking medications, following a recommended diet, and/or executing lifestyle changes) 
corresponds with the agreed recommendations of health professionals”. [8] The definition 
also includes the “active, voluntary, and collaborative involvement of the patient in a 
mutually acceptable course of behavior to produce a therapeutic result”. [9] Adherence to 
diabetes treatment is typically measured by the number of times the patient administers 
insulin at the prescribed times, self-monitors blood glucose follows the prescribed diet, 
and performs physical exercises at least 20 minutes a day. [10] There is no standard 
method for measuring adherence, and all measurement approaches include both direct 
and indirect measures. Direct measures of adherence behavior include the assessment of 
metabolite blood levels and the measurement of clinical outcomes of diabetes such as 
glycated hemoglobin. However, these methods are expensive, depend on information 
technology, require training, and provide a general reflection of adherence to the 
therapeutic regimen (i.e. elevated glycated hemoglobin could indicate low adherence to 
insulin regimen and/or diet). [11] 
Indirect measures of adherence behavior include self-report questionnaires, 
parents’ reports, healthcare provider reports, and structured interviews. These methods 
are less expensive, easy to administer, and provide more details on patient’s adherence to 
specific management tasks. However, these methods are prone to several types of 
information bias such as recall bias, interviewer bias, and prevarication bias. [12] On the 
other hand, self-report questionnaires demonstrated effective evaluation of adherence. 
[12] However, when patients rate their degree to which they follow the recommended 
therapeutic regimen they overestimate adherence due to several factors such as wording 
and the structure of the questions. [13]  
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As adolescents receive complex and intensive medical regimens, it becomes 
critical to have psychometrically robust assessment methodology to monitor their 
adherence. [14] For the purpose of this study, adherence is conceptually defined as the 
extent to which an individual’s action or behavior coincides with advice or instruction. 
Several self-report measures have been developed to measure adherence such as Diabetes 
Self-Management Profile–Self Report (DSMP-SR) [15], Diabetes Management 
Questionnaire (DMQ) [16], and ADQ. [6] 
The DSMP-SR [15] is a 24-item self-report or parent-report questionnaire 
developed to measure adherence in children and adolescents with T1D aged ≥ 11years 
old. The instrument was developed based on the DSMP interview guide [17] to decrease 
the requirement for trained interviewers to conduct the DSMP interviews. The instrument 
has separate versions for patients on insulin pump versus conventional daily insulin 
injections. [15] Items inquire about how often adolescents adhere to specific diabetes 
management task and respondents select answers from 3 to 6 options for each question. 
Psychometric properties of the DSMP-SR were evaluated in a sample of 151 youth with 
T1D. [15] Evidence of reliability includes Cronbach’s alpha of .82 for youth and .80 for 
parents suggesting adequate internal consistency. [18] With no available data to support 
the construct validity of the instrument, results on convergent validity showed moderate 
correlations between DSMP-SR and PedsQL diabetes module for youth and parents (r = 
.37 and .49, respectively). [15] 
The DMQ [16] is a 20-item instrument developed to measure adherence to 
diabetes self-management tasks in children with T1D over the last month of therapy. [16] 
The instrument has five subscales as follows: physical activity (3 items), meal and snack 
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time (8 items), low blood sugar (3 items), high blood sugar (3 items), and insulin and 
blood sugar monitoring (3 items). Response options are based on a 5-point Likert scale 
ranging from 1 (almost never) to 5 (almost always). The content of the DMQ was based 
on previously developed instruments including the self-care inventory and the diabetes 
self-management profile. [16] Psychometric properties of the DMQ were evaluated in a 
sample of T1D children (N =273). Evidence of reliability includes Cronbach’s alpha (α) 
of.79 [16], suggesting inadequate internal consistency, and test-retest coefficient of .65 
with a 6-week interval [16]; suggesting inadequate stability of the instrument. [18] 
Results on convergent validity indicated a moderate correlation between the DMQ scores 
and blood glucose monitoring frequency (r = .36). [16] 
The Instrument 
The ADQ [6] is a 17-19-item self-report questionnaire developed to evaluate 
adherence behavior activities of adolescents and children with T1D. [6] The instrument 
has two versions based on insulin modality; ADQ-I has 17 items pertaining to adherence 
for patients on insulin pump, whereas ADQ-C has the same 17 items in the ADQ-I with 
two additional items related to adherence for patients on conventional insulin 
administration. The aim is to assess adolescents’ adherence to daily diabetes treatment 
practices including physical activity, dietary management, insulin administration and 
adjustment, collaboration with caregivers, and daily glucose measurement. Both ADQ-I 
and ADQ-C have a separate self-report version for children aged 10 years and older; 
ADQ-I-C and ADQ-C-C, plus a separate version for parents or caregiver of children 
younger than 10 years; ADQ-I-P and ADQ-C-P with similar item content. [6] 
Respondents rate each item on a 5-point Likert scale ranging from 1 = “have not done it 
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at all” to 5 = “have always done it”. The measurement framework for this instrument is 
norm-referenced measurement where higher mean scores indicate greater adherence. [6] 
The development of the ADQ was based on a previously developed instrument that 
measures adherence in patients with diabetes; the Diabetes Behavior Rating Scale 
(DBRS). The instrument was found to be easy to read and takes less than 10 minutes to 
complete. [6] 
Psychometric properties of the ADQ were evaluated in a sample of 1028 
caregivers and 766 adolescents (aged 10-17) with T1D. [6] All versions of the ADQ 
demonstrated satisfactory internal consistency with α = .85 for the ADQ-C-C; .82 for the 
ADQ-I-C; .89 for the ADQ-C-P; and .86 for the ADQ-I-P. [6] Construct validity showed 
a four-factor solution for ADQ-C-P and ADQ-I-P with almost all items uniquely loaded 
(≥ .40) onto each factor suggested in the final solution of the ADQ. [6] Convergent 
validity results showed a significantly strong correlation between the ADQ items and a 
parallel measuring scale (The Self-Efficacy for Diabetes Self- Management) items (r = 
.61, p= .001). [6] Thus, this instrument meets the a priori criteria for reliability (≥ .80), 
convergent validity (≥ .50), factorial validity, and readability.  The ADQ is simple, easy 
to complete, has separate versions for patients on insulin pump and patients on 
conventional daily insulin injections, has acceptable psychometric properties, and 
adequately covers adherence activities with regard to insulin administration, physical 
activity, monitoring blood glucose, diet, management of hypo and hyperglycemia, 
appointment keeping(repeat of above). Furthermore, the instrument asks adolescents to 
report what they actually do regarding the diabetes treatment plan in the preceding 
month, which decrease the risk of recall bias compared with 2-3 months in other 
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instruments. In addition, the instrument is available in the public domain and can be used 
for free. For the proposed study, adherence is operationally defined by measuring self-
reported self-care behaviors in the preceding month as score in the Arabic version of the 
ADQ. While the population in this study will be adolescents aged between 12 and 18 
years, the translation will be performed for ADQ-I-C and ADQ-C-C. Since the first 17 
items are similar in both versions, and ADQ-C-C has two additional items for patients on 
daily insulin injections, the study will translate and psychometrically test the ADQ-C-C, 
and from the final adopted version, a separate version will be created for patients on 
insulin pump by removing the last two items. 
Methods and Design 
The aim of this study is to translate the ADQ-C-C version of the ADQ into Arabic 
and examine the psychometric properties of the Arabic version in Jordanian adolescents 
with T1D. It is anticipated that the translation process and data collection will commence 
in November 2017 and continues through April 2018.The psychometric protocol 
presented in this paper is divided into two phases. The successful completion of the first 
phase will produce an Arabic version of the questionnaire (ADQ-C-C-Arabic) with 
initially accepted psychometric properties that will be further tested for reliability and 
validity in a larger sample of Arabic speaking adolescents with T1D. The second phase 
includes the psychometric evaluation of the adapted version in a larger sample (N=500) 
of Jordanian adolescents aged 12 to 18 years with T1D. The outcome of this phase is to 
produce a valid and reliable Arabic version of the source questionnaire (ADQ) that could 
be used to measure regimen adherence in Arabic speaking adolescents with T1D. 
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Phase I: Translation and Cross-Cultural Adaptation of the ADQ-C-C 
The translation will be guided by the guidelines of translation and cross-cultural 
adaptation of self-report measures recommended by Beaton et al [19]. The guidelines 
include five consecutive stages as follows: initial translation, synthesis of the translations, 
back translation, expert committee, and test of the pre-final version. First, the PI will send 
an e-mail letter to the original developers of the ADQ requesting for permission to 
proceed with the translation and use of the instrument for research purposes. After 
receiving the permission, the guidelines of translations will be followed. 
Phase 1.1: Initial Translation 
Two forward translations of ADQ-C-C will be made from English to Arabic by 
two independent bilingual translators whose native language is Arabic. One of them 
will be a certified endocrinologist who is aware of the study’s purpose and goals, and 
the other one will be a linguistics faculty who has no clinical or medical background 
and will be blinded to the concepts being quantified in the questionnaire. Both 
translators will be simultaneously be given the same instructions for translation. Each 
translator will produce a translated version of the instrument combined with a written 
report of the translation. The PI will assign each translated version with the initial 
name as follows: ADQ-C-C-T1 and ADQ-C-C-T2. 
Phase 1.2: Synthesis of the Translations 
Both translators will be advised to schedule a meeting to discuss the differences 
between their translations, highlight challenging phrases or uncertainties, and resolve any 
differences. Both translations (ADQ-C-C-T1 and ADQ-C-C-T2) with the original 
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questionnaire (ADQ-C-C) will be synthesized to produce a common translated version 
that will be called ADQ-C-C-T3. This phase will be concluded with a written report 
documenting the synthesis process, addressed issues, and how they resolved each issue. 
Phase 1.3: Back Translation 
Two back translations of the ADQ-C-C-T3 version into English will be done by 
two independent bilingual translators whose native language is English. The two 
translators have no clinical or medical background and will not be aware of the concepts 
being explored. The back translations will be conducted with no prior exposure to the 
English version of the questionnaire. Two independent versions will be produced in this 
stage: back translation 1 (ADQ-C-C-BT1), and back translation 2 (ADQ-C-C-BT2). The 
purpose behind this process is to confirm that the back-translated versions are contently 
identical to the original version. A synthesis of these translations will be performed to 
produce one common translation and the PI will give a name for this version as ADQ-C-
C-BT3. 
Phase 1.4: Expert Committee 
Phase 1.4.1: An expert committee will be formulated to discuss any discrepancies 
between the original ADQ-C-C items and the back-translated version of the instrument. 
The committee will consist of two endocrinologists, one pediatrician, two diabetes 
nurses, an Arabic language expert, the translators (forward and back-translators), and the 
PI. The diversity of the expert committee is to consolidate the process and enrich the 
content validity of the questionnaire. The end result of this sub-phase is to integrate all 
translated version of the questionnaire and create a unified version that would be 
considered as the pre-final version for field testing. The decision on the equivalency 
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between the original and the developed versions will consider the concepts of idiomatic, 
semantic, experiential, and conceptual equivalencies. 
Phase 1.4.2: Once the agreed version is obtained (ADQ-C-C-Arabic-1), content 
validity will be examined using the content validity index (CVI). The aim of this analysis 
is to examine the appropriateness of the ADQ-C-C-Arabic-1 in measuring adherence in 
Arabic-speaking adolescents with T1D. To conduct the content validity analysis, the PI 
will invite a larger number of experts from the field of diabetes management. 
The content validity of the adopted version of the ADQ-C-C will be tested with a 
committee of experts in diabetes care using the CVI. The CVI will be computed for each 
item (I-CVI) and for the total scale (S-CVI). The I-CVI represents the percentage of 
experts who consider an item clearly represents the content, while S-CVI represents the 
percentage of items considered as clearly represent the content by all experts. [20]The PI 
will develop a content validity questionnaire in which each item in the ADQ-C-C-
Arabic1 version is rated on a 4-point Likert scale: 1) not clearly represent the content; 2) 
somewhat clear and represent the content; 3) quite clear and represent the content; 4) 
highly clear. 
Content validity questionnaire exemplar:  
Item Clearly represent the content Comment 
Planning meals in accordance with the 
system that you’ve been taught? 
1     2     3     4    
Note: The questionnaire will be in Arabic 
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After ranking by the panel members, the PI will dichotomize the ratings of 3 or 4 
as clearly represent the content item and ratings of 1 or 2 as not clearly represent the 
content item. The PI will calculate the I-CVI for each item by dividing the number of 
experts who rated the item with 3 or 4 (clearly represent the content), by the total number 
of experts. For example, if an item was rated as clearly represent the content by 8 out of 
10 experts, the I-CVI for this particular item will be .80. For this study, the following a 
priori criteria of the I-CVI are established: ≥ .80 indicates acceptable content validity of 
individual item; ≤ .60 and ≥ .79 indicates revision, and ≤ .59 indicates deletion or 
substitution. The averaging calculation method will be used to compute the scale-level 
content validity index (S-CV1/Ave) by calculating the average of the I-CVIs for all items 
on the scale. A priori S-CV1/Ave of ≥ .80 is established for acceptable content validity 
and that the first Arabic version of the scale is semantically equivalent to the ADQ-C-C. 
Phase 1.5: Test of the Pre-final version (ADQ-C-C-Arabic-2) 
 The final product of the translation process will be the Arabic version of the 
instrument (ADQ-C-C-Arabic-2). A separate version for patients on insulin pump will be 
created by removing the last two items and will be named as ADQ-I-C-Arabic-2. The 
final versions will be pilot tested for face validity in a sample of 60 Jordanian adolescents 
with T1D, 30 adolescents on daily insulin injections modality, and 30 adolescents on 
insulin pump. The study proposal will be submitted to the Ethics Committee of 
University of Texas Health Science Center at Houston and King Abdullah University 
Hospital (KAUH), Jordan, for ethical approval. The selected participants will be asked to 
complete the ADQ-C-C-Arabic-2 when they are waiting to be seen by the physician or 
after they finish their appointment. The PI will provide the participant the ADQ-C-C-
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Arabic-2and explain how to respond to each item in term of the extent that each item best 
describes how he/she have managed his/her diabetes care in the preceding month using 
the following scale: 1 = “Have not done it at all”,  2 = “Have seldom done it”, 3 = “Have 
done it about half the time”,  4 = “Have usually done it”, and 5 = “Have always done it”. 
A mini-cognitive interview will be conducted with each participant when they finished 
the questionnaire to get a deeper understanding of what each item and response meant to 
the respondent. The PI will ask each participant for any further comments and if they 
struggled with any item or was difficult to understand. To examine face validity of the 
ADQ-C-C-Arabic-2, participants will be asked to rate the ability of the scale to measure 
adherence as it appears to them using the following Likert scale: 1) the scale is extremely 
suitable, 2) the scale is very suitable, 3) the scale is adequate, 4) the scale is inadequate, 
and 5) the scale is irrelevant and therefore unsuitable. A priori criterion of 80% of the 
participants reported each scale as valid is established to assume that the Arabic versions 
are culturally adapted and ready for further psychometric evaluation. In addition, the 
following operational specifications will be considered in the adaptation of the translated 
version: the instrument is semantically equivalent to the ADQ, is self-administered; easy 
to read; appropriate for adolescents aged 12-18 years; takes between 10 to 15 minutes to 
complete; and covers adherence to medication, diet, exercise, glucose management, and 
insulin regimen; evidence of reliability in Arabic speaking adolescents with T1D ≥.80 
and evidence of validity ≥ .50. 
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Phase II: Further Testing of the Adapted Version 
The aim of this phase is to evaluate the consistency of the ADQ-C-C-Arabic and 
ADQ-I-C-Arabic to accurately measure adherence among Arabic-speaking adolescents 
with T1D. 
Study design and participants. A cross-sectional study design will be employed 
to psychometrically assess the ADQ-C-C-Arabic and ADQ-I-C-Arabic in a convenience 
sample of Jordanian adolescents aged 12 to18 years with T1D. The study will test the 
final adopted versions for internal consistency reliability, test-retest reliability, and 
construct validity. Inclusion criteria for study participants are as follows: Jordanian 
adolescents diagnosed with T1D, age between 12 and 18 years, initiated on treatment that 
includes daily insulin injections or insulin pump, and able to read and write Arabic.  
 Item Response Theory (IRT) of measurement will be utilized to evaluate the 
psychometric performance of the Arabic version of the ADQ-C-C.  IRT is a system of 
statistical models that describes one way of determining the consistency between latent 
traits and their manifestations.  IRT is applied to minimize the bias and maximize the 
measurement power of psychological tests and psychometric questionnaire. [21] In 
healthcare, several concepts demonstrate the pattern of continuity which may be ranked 
from lowest to highest such as adherence and quality of life. In this case, scale 
development should consider the way in which items are constructed and ordered to 
reflect the underlying latent variable. The IRT allows the researchers to consider the issue 
of ordering that would provide a better understanding of the concept and measure 
individual responses more accurately. [22] Since the ADQ-C-C uses the Likert scale in 
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measuring adherence, the Graded Response Model (GRM), one of the Rasch models used 
for ordered polytomous data, will be applied in this study. The GRM visualizes the 
relationship between responses to an item and the trait levels (theta, θ), assuming that an 
increase in an individual’s response will result in a continuum step toward higher degree 
of the latent variable, here adherence. There are two basic assumptions that must be met 
when using IRT; unidimensionality and local independence (LI). [21] 
Unidimensionality means that the latent variable being measured is, in fact, 
unidimensional; that is, items in the Arabic version of the ADQ-C-C measure only the 
underlining construct (i.e. adherence) and the covariance among the items can be 
explained only by that construct. Confirmatory factor analysis (CFA) and an exploratory 
factor analysis (EFA) will be conducted to evaluate this assumption. When CFA is 
applied to test the unidimensionality assumption of the IRT, a model is determined when 
all items adequately load on a single factor. [23] The CFA for GRM goodness of fit will 
be assessed based on the following a priori criteria: the Comparative Fit Index of ˃ .95, 
the Standardized Root-Mean Residual (SRMR) of ˂ .08, the Non-Normed Fit Index 
(NNFI) of >.95, and the Root-Mean-Square Error of Approximation (RMSEA) of ˂.06. 
[24] If the CFA failed to provide best GRM fit, an EFA will be conducted and the 
unidimensionality of the scale will be accepted if the first extracted factor accounted for 
20% or more of the total variance explained by the model or if the ratio of the first 2 
eigenvalues exceeds 4. [25] The assumption of LI means that the individual’s response to 
any item does not affect the response for other items. This assumption will be evaluated 
by examining the residuals extracted from the EFA analysis. The LI will be considered 
solid criterion for model fit if the residuals approaching zero (≤.20). [25] 
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The sample size is determined based on the number of subjects needed to achieve 
an adequate calibration of GRM. According to De Ayala [21], at least 500 subjects will 
be required. Based on the insulin modality, the ADQ-C-C-Arabic or ADQ-I-C-Arabic 
will be administered on two separate occasions two weeks apart to calculate test-retest 
reliability. Authorization will be granted from the personnel in-charge of the selected 
clinic. 
Data Management  
Two separate datasets will be created in SPSS for each version; one for the data 
collected in the first round, and one for data collected in the second round. 
Data analysis and interpretation. Statistical analysis will be performed by the 
Principal Investigator (PI) using SPSS (version 24) and Amos 7.0.  
Construct validity. CFA will be used to investigate the construct validity of the 
ADQ-C-C-Arabic and ADQ-I-C-Arabic. The RMSEA, the CFI, and the SRMR will be 
computed to evaluate the fitness of the GRM based on the a priori criteria mentioned 
above. If the CFA failed to prove the goodness of GRM fit, an EFA will be performed 
using principal axis factoring with orthogonal rotation (Varimax). The Kaiser-Meyer 
Olkin test ≥ .60 will be used to determine the sample adequacy for analysis. [26] The 
number of factors will be determined by Kaiser’s rule where only the factors that have 
eigenvalues greater than one were retained for interpretation. [26] A priori criteria of 
factor pattern loadings ≥ .40 with cross-loadings ≥.20 [27], and a minimum of three items 
per factor will be used for acceptable and interpretable factor solution. [28] 
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Internal consistency reliability. Cronbach's alpha coefficient will be used to 
evaluate the internal consistency of ADQ-C-C-Arabic and ADQ-I-C-Arabic. Cronbach's 
alpha coefficient will be computed for the total scale (17 or 19 items). A priori criterion 
of α ≥ .80 will be used for adequate evidence of the scales consistency. [18] 
Test-retest reliability. The Pearson product moment correlation coefficient (r) test 
will be used to examine the stability of the instruments. A priori criterion of r ≥ .80 is 
established for adequate evidence of stability of the questionnaires. [18] 
Discussion 
The Arabic language is broadly considered as one of the most difficult languages 
to use in the translation of instruments, therefore issues in the translation process may 
arise especially when translating the medical terminology, which might be understood 
and translated differently by subjects due to the diverse accents that are common in the 
Arabic language. [29]To account for this issue, the translators will be advised to use 
popular terms that are age and gender appropriate and can be easily understood by the 
target population. Moreover, they will be advised to select jargon-free terms and avoid 
using medical and nursing terms in order to avoid misinterpretation that may arise due to 
different accents within Jordanian context. [29] Another issue related to the scale use is 
that the questionnaire is self-report which increase the risk of recall bias. This issue will 
be minimized by asking the parents to help their children if they cannot exactly remember 
their self-care activities in the preceding month. 
If the instrument demonstrated unsatisfactory psychometric properties in term of 
reliability and validity, several alternative plans are proposed to be followed. First, if the 
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pre-final version of the instrument does not meet the a priori criterion for S-CVI, the 
translation will be replicated. Second, if the instrument failed to demonstrate adequate 
face validity levels, the PI will conduct small focus groups of Jordanian adolescents with 
T1D to discuss the contents of the instrument and address any inappropriate contents that 
may lead to inaccurate measurement of adherence. Third, if the translated instrument is 
found to have satisfactory levels of content and face validity but failed to meet the a 
priori criteria for construct validity and/or internal consistency reliability, the translated 
instrument will be considered invalid and unreliable to measure the concept of interest 
and the PI will propose a new study protocol to measure regimen adherence using the 
original ADQ in a sample of English-speaking Jordanian adolescents with T1D. Before 
data collection, a pilot study will be conducted on a convenience sample of 20 Jordanian 
adolescents aged 12 to18 years with T1D to test the internal consistency reliability of the 
ADQ. If the preliminary results showed unsatisfactory levels of the reliability estimates, 
the PI will search for a new instrument that fits with the operational specifications 
proposed in this study and replicate the translation and cross-cultural adaptation producer 
in order to produce a valid and reliable instrument to measure regimen adherence in 
Arabic speaking population. 
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List of abbreviations 
ADQ: Adherence in Diabetes Questionnaire 
ADQ-C: Adherence in Diabetes Questionnaire-Conventional  
ADQ-C-C: Adherence in Diabetes Questionnaire-Conventional-Children 
ADQ-C-P: Adherence in Diabetes Questionnaire-Conventional-Parents 
ADQ-I: Adherence in Diabetes Questionnaire-Insulin  
ADQ-I-C: Adherence in Diabetes Questionnaire-Insulin-Children 
ADQ-I-P: Adherence in Diabetes Questionnaire-Insulin-Parents 
CFA: Confirmatory Factor Analysis 
CFI: Comparative Fit Index 
CVI: Content Validity Index 
DBRS: Diabetes Behavior Rating Scale 
DMQ: Diabetes Management Questionnaire 
DSMP: Diabetes Self-Management Profile 
DSMP-SR: Diabetes Self-Management Profile–Self Report 
EFA: Exploratory Factor Analysis 
GRM: Graded Response Model 
IRT: Item Response Theory  
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LI: local Independence  
NNFI: Non-Normed Fit Index 
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S-CV1/Ave: Scale-Level Content Validity Index 
SRMR: Standardized Root-Mean Residual 
 T1D: Type 1 diabetes 
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Yousef Aljawarneh 
UT-H - SN - Acute and Continuing Care Dept 
NOTICE OF APPROVAL TO BEGIN RESEARCH
 
October 10, 2017 
HSC-SN-17-0852 - Associations between Physical Activity, Health-Related Quality 
of Life, Regimen Adherence, and Glycemic Control in Jordanian Adolescents with 
Type 1 Diabetes 
Number of Subjects Approved: Target: /Screen: 150 
PROVISIONS: This approval relates to the research to be conducted under the above 
referenced title and/or to any associated materials considered by the Committee for the 
Protection of Human Subjects, e.g. study documents, informed consent, etc. 
APPROVED: By Expedited Review and Approval 
REVIEW DATE: 10/06/2017 
APPROVAL DATE:10/10/2017 
EXPIRATION DATE: 09/30/2018 
CHAIRPERSON: L. Maximilian Buja, MD 
Subject to any provisions noted above, you may now begin this research. 
CHANGES: The principal investigator (PI) must receive approval from the CPHS before 
initiating any changes, including those required by the sponsor, which would affect human 
subjects, e.g. changes in methods or procedures, numbers or kinds of human subjects, or 
revisions to the informed consent document or procedures. The addition of co-investigators 
must also receive approval from the CPHS. ALL PROTOCOL REVISIONS MUST BE 
SUBMITTED TO THE SPONSOR OF THE RESEARCH. 
INFORMED CONSENT DETERMINATION: 
Signed Informed Consent Required 
INFORMED CONSENT: When Informed consent is required, it must be obtained by the 
PI or designee(s), using the format and procedures approved by the CPHS. The PI is 
responsible to instruct the designee in the methods approved by the CPHS for the consent 
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process. The individual obtaining informed consent must also sign the consent document. 
Please note that only copies of the stamped approved informed consent form can be used 
when obtaining consent. 
 
HEALTH INSURANCE PORTABILITY and ACCOUNTABILITY ACT (HIPAA): 
Exempt from HIPAA: This study is being conducted outside the United States and 
therefore, is not bound by HIPAA laws. 
UNANTICIPATED RISK OR HARM, OR ADVERSE DRUG REACTIONS: The PI 
will immediately inform the CPHS of any unanticipated problems involving risks to 
subjects or others, of any serious harm to subjects, and of any adverse drug reactions. 
RECORDS: The PI will maintain adequate records, including signed consent and HIPAA 
documents if required, in a manner that ensures subject confidentiality. 
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Volunteers with Type 1 
Diabetes Needed for Research Study 
This study looks at the relationships between physical activity, health-related quality of 
life, adherence, and glycemic control in adolescents with Type 1 Diabetes. This study 
will be conducted by Mr. Yousef Aljawarneh under the supervision of clinical and 
academic professors from King Abdullah University Hospital in Jordan, and The 
University of Texas Health Science Center at Houston in the USA. 
You may be eligible to participate if: 
  You have been diagnosed with Type 1 Diabetes for more than 1 year.  
  You are 12 to 18 years old. 
  In good general health. 
Study details:  
As a participant in this study, you will be asked to fill anonymous questionnaires related 
to the study in a single session which is approximately 15 minutes. 
 Location: 
The Pediatric Diabetes Clinic at King Abdullah University Hospital, 3rd floor, Section C. 
The study has been reviewed and approved by the Research Ethics Committees at 
KAUH (Jordan) and UTHealth (USA) 
 
IRB NUMBER: HSC-SN-17-0852 
  
IRB APPROVAL DATE: 10/10/2017 
Interested? 
For more information about the study, or to volunteer for this study, please contact: 
Yousef Aljawarneh, Mobile: 00962798097033 
Dr. Mohammad Aljarrah, Mobile: 00962798167489 
Clinic Nurse: 0096227200600 
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مطلوب متطوعيين للمشاركة في دراسة بحثّية عن 
  1النوع -مرض السكري
العلاجية، ونسبة السكر يهدف هذا البحث إلى دراسة العلاقة بين النشاط البدني، جودة الحياة ، الإمتثال بالخطة 
. وسيجري هذه الدراسة  طالب الدكتوراة 1التراكمي في الدم لدى المراهقين المصابيين بمرض السكري من النوع 
يوسف الجوارنة تحت إشراف أساتذة سريريين وأكاديميين من مستشفى الملك المؤسس عبد الله الجامعي في 
  المتحدة الأمريكية.الأردن، وجامعة تكساس في هيوستن بالولايات 
 قد تكون مؤهلا ًللمشاركة إذا:
 لمدة تزيد عن سنة واحدة. 1النوع  -تم تشخيصك بمرض السكري 
 سنة. 81-21عمرك  
 تتمتع بصحة جيدة. 
 تفاصيل الدراسة:
 دقيقة. 51كمشارك في هذه الدراسة, سيطلب منك ملء إستبيانات تتعلق بالدراسة في جلسة واحدة و هي حوالي 
 المكان: 
  عيادة سكري الأطفال في مستشفى الملك المؤسس عبدالله الجامعي, الطابق الثالث.
تّم مراجعة الدراسة و الموافقة عليها من قبل لجان أخلاقيات البحوث العلمية في مستشفى الملك المؤسس عبدالله 
 الجامعي (الأردن) و جامعة تكساس (هيوستن, الولايات المتحدة الأمريكية).
 2580-71-NS-CSH :REBMUN BRI
  
 7102/01/01 :ETAD LAVORPPA BRI
  مهتم أو ترغب بالمشاركة؟ 
 لمزيد من المعلومات أو المشاركة في الدراسة الرجاء الإتصال بالأرقام التالية:
  33079089726900يوسف الجوارنة , تلفون: 
  98476189726900الدكتور محمد الجراح, تلفون: 
  0060027226900عيادة سكري الأطفال, تلفون: 
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Date: …………………………… Participant Code Number: ……………………………… 
 
 
 
Patient consent form for conducting scientific research 
Patient Name: ……………..…………………………………… MRN #............................. 
Name of the Researcher: ………………………………………Phone # …………………. 
Study Title: ……………………………………………………………………………… 
Before I agreed to participate in the research I was informed by the researcher with the 
following: 
1. Approval by the concerned authorities in the hospital for conducting the study 
2. Study objectives and procedures 
3. Any potential and foreseeable risks and any inconvenience or benefits arising from the 
study 
4. Any alternative or potential procedures or treatments 
5. Unexpected risk potential 
6. Any compensation or insured medical treatment in the event of harm or damage as a 
result of the study 
7. Duration of the study 
8. Data confidentiality procedure 
9. Cases that may prompt the researcher to stop me from participating in the study 
10. Any additional effort I could make for the study. 
11. What happens if I decide to withdraw from the study? 
12. When should I be informed of new conclusions that may affect my determination to 
participate in the study 
If you have questions about your rights as a participant in this study or what you should do if 
you are harmed, you can call at any time: 
Name:…………………………………………..Phone…………………………………. 
Your participation in this study is voluntary and optional. You will not be penalized or lose 
any benefits if you decide not to participate or withdraw from the study at any time. Once 
you sign this document you acknowledge that you agree to voluntarily participate in this 
study and that the above information is fully explained. 
Date 
------------------ 
Name of the Participant 
----------------------------------------------------------- 
Signature 
--------------------------------------- 
Date  
------------------ 
 
Date  
------------------ 
First Witness 
----------------------------------------------------------- 
 
Second Witness 
----------------------------------------------------------- 
Signature 
--------------------------------------- 
 
Signature 
---------------------------------------- 
Date 
------------------ 
Name of the Researcher 
----------------------------------------------------------- 
Signature 
----------------------------------------- 
Important Note: A copy of this form must be saved in the patient's medical file 
IRB NUMBER: HSC-SN-17-0852 
IRB APPROVAL DATE: 10/10/201 
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Informed Consent – Arabic Version 
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 ……………………………… :rebmuN edoC tnapicitraP …………………………… :etaD
                                                 
 نموذج موافقة المريض على إجراء بحث علمي
  ................................................................ الرقم الطبي: ...........................................إسم المريض: 
  رقم الهاتف: ........................................... إسم المشرف على البحث: ...................................................
  ............................................................................................... ث: ............................ن البحعنوا
 :يلي بما الباحث قبل من إعلامي تم البحث في المشاركة على موافقتي قبل 
 .البحث إجراء على المستشفى في المعنية الجهات موافقة .1
 .إجراءاته و البحث أهداف .2
 .البحث عن ناتجه منافع أو مضايقات أّية و متوقعة و ممكنة أخطار أّية .3
 .محتملة أو بديلة علاجات أو إجراءات أّية .4
 .متوقعة غير خطورة إحتمال .5
 زالبحث نتيجة ما ضرر أو أذى حدوث حال في لي مؤّمن طبي علاج أو تعويضات أّية .6
 .للبحث اللازمة الزمنية المدة .7
 .المعلومات سّرية على الحفاظ كيفية .8
 .البحث في المشاركة عن إيقافي على الباحث تحث أن الممكن من التي الحالات .9
 .البحث لغاية أبذله أن ممكن إضافي جهد إي .01
 .البحث في المشاركة عن اتوقف أن قررت حال في يحدث ماذا .11
 بحث.المشاركة في ال فيتؤثر على عزمتي  ممكن أن جديدة بإستنتاجات  يتوجب إعلامي متى .21
 إو أذىب إصابتك حال في عمله عليك يتوجب فيما أو البحث هذا في كمشارك بحقوقك تتعلق ما أسئلة لديك كان إذا 
 ب: الأوقات من وقت أي في الإتصال الممكن فمن ضرر
   ............................................. ............................................................................ على الرقم
 نم الإنسحاب أو المشاركة عدم قررت حال في منافع أّية تخسر أو تعاقب فلن إختيارية البحث هذا في مشاركتك 
 .وقت أي في الدراسة
 تالمعلوما أن و الدراسة هذه في المشاركة على إختياريا توافق بأنك ُتقر فأنت المستند هذا على توقيعك بمجرد 
 .بالكامل ُشرحت أعلاه المدونه
 توقيعه
 ...........................................
 إسم المشارك
 ..........................................
 التاريخ
  ..........................................
 توقيعه
  ...........................................
 توقيعه
 ...........................................
 إسم الشاهد الأول
  ...........................................
 إسم الشاهد الثاني
 ............................................
 التاريخ
  ..........................................
  التاريخ
  ..........................................
 توقيعه
 ............................................
 إسم المشرف على البحث
  ..........................................
 التاريخ
  ..........................................
 لاحظة هامة: يجب حفظ نسخة من هذا النموذج في الملف الطبي للمشاركم 
 2580-71-NS-CSH :REBMUN BRI
  
 7102/01/01 :ETAD LAVORPPA BRI
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Appendix G 
 
The Pediatric Quality of Life Inventory 3.0 Diabetes Module – English Version 
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The Pediatric Quality of Life Inventory 3.0 Diabetes Module – Arabic Version 
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Date: …………………………… Participant Code Number: ………………………………. 
International Physical Activity Questionnaire 
Short Last 7 Days Self-administered Format 
We are interested in finding out about the kinds of physical activities that people 
do as part of their everyday lives.  The questions will ask you about the time you 
spent being physically active in the last 7 days.  Please answer each question 
even if you do not consider yourself to be an active person.  Please think about 
the activities you do at work, as part of your house and yard work, to get from 
place to place, and in your spare time for recreation, exercise or sport. 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous 
physical activities refer to activities that take hard physical effort and make you 
breathe much harder than normal.  Think only about those physical activities that 
you did for at least 10 minutes at a time. 
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling?  
_____ Days per week  
               No vigorous physical activities  Skip to question 3 
2. How much time did you usually spend doing vigorous physical activities on one 
of those days? 
 
_____ Hours per day  
_____ Minutes per day  
 
  Don’t know/Not sure  
 
Think about all the moderate activities that you did in the last 7 days.  Moderate 
activities refer to activities that take moderate physical effort and make you 
breathe somewhat harder than normal.  Think only about those physical activities 
that you did for at least 10 minutes at a time. 
3. During the last 7 days, on how many days did you do moderate physical 
activities like carrying light loads, bicycling at a regular pace, or doubles 
tennis?  Do not include walking. 
_____ Days per week 
             No moderate physical activities  Skip to question 5 
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4. How much time did you usually spend doing moderate physical activities on one 
of those days? 
 
_____ Hours per day 
_____ Minutes per day 
 
  Don’t know/Not sure  
 
Think about the time you spent walking in the last 7 days.  This includes at work 
and at home, walking to travel from place to place, and any other walking that 
you have done solely for recreation, sport, exercise, or leisure. 
5. During the last 7 days, on how many days did you walk for at least 10 
minutes at a time?  
_____ Days per week  
   No walking     Skip to question 7 
6. How much time did you usually spend walking on one of those days? 
 
_____ Hours per day 
_____ Minutes per day  
 
  Don’t know/Not sure  
 
The last question is about the time you spent sitting on weekdays during the last 7 days.  
Include time spent at work, at home, while doing course work and during leisure time.  
This may include time spent sitting at a desk, visiting friends, reading, or sitting or lying 
down to watch television. 
7. During the last 7 days, how much time did you spend sitting on a week day? 
 
_____ Hours per day  
_____ Minutes per day  
 
  Don’t know/Not sure  
 
 
This is the end of the questionnaire, thank you for participating. 
 
IRB NUMBER: HSC-SN-17-0852 
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 .……………………………… :rebmuN edoC tnapicitraP …………………………… :etaD
 )cibarA( eriannoitseuQ ytivitcA lacisyhP
  ستبانة النشاط البدني الدوليةا
  ماضية ال ةلقياس مستوى النشاط البدني في الأيام السبع    
   الصيغة المختصرة للاستبانة، للاستخدام عن طريق التعبئة الشخصية
نحن مهتمون بمعرفة أنواع الأنشطة البدنية التي يقوم بها الأفراد كجزء من حياتهم اليومية. الأسئلة التالية ترتكز حول الوقت 
ة أنشطة بدنية خلال الأيام السبعة الماضية. فضًلا أجب عن كل سؤال من الأسئلة التالية حتى وا  ن الذي قضيته في ممارس
كنت تعتبر نفسك غير نشيط بدنيًا. فكر في الأنشطة البدنية التي تمارسها خلال عملك، وكجزء من أعمالك المنزلية، وأثناء 
  .رض الترويح أو التمرين أو الرياضةتنقلك من مكان لآخر، وتلك التي تقوم بها في وقت فراغك بغ
الآن فكر في جميع الأنشطة البدنية التي تتطلب جهدًا بدنيًا مرتفع الشدة والتي قمت بممارستها خلال الأيام السبعة الماضية. 
و حرث الأنشطة البدنية مرتفعة الشدة هي تلك الأنشطة التي تجعل تنفسك أعلى بكثير من المعتاد، مثل رفع أشياء ثقيلة، أ
الأرض، أو ركوب الدراجة بسرعة عالية، أو الجري، أو ممارسة كرة القدم، أو كرة السلة، أو السباحة، أو نط الحبل.  فكر 
  دقائق على الأقل في كل مرة.  01فقط في الأنشطة البدنية مرتفعة الشدة التي قمت بممارستها لمدة 
 
 نشاطًا بدنيًا مرتفع الشدة؟، كم يومًا مارست فيه الماضية ةالأيام السبعخلال  -1
  ____  يوم في الأسبوع    
  3إلى السؤال رقم  مباشرة انتقللا أقوم بأي نشاط بدني مرتفع الشدة.                                  
 في المعتاد، كم من الوقت قضيته في ممارسة نشاط بدني مرتفع الشدة في أحد تلك الأيام؟   -2
  م  ____   ساعة في اليو  
 ____   دقيقة في اليوم   
               لا أدري/ أو غير متأكد.
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والتي قمت بممارستها خلال الأيام  معتدل الشدةالآن فكر في جميع الأنشطة البدنية التي تتطلب جهدًا بدنيًا 
، المعتاد إلى حدًا ماأعلى من الشدة هي تلك الأنشطة التي تجعل تنفسك  معتدلةالماضية. الأنشطة البدنية السبعة 
تنس ، أو ممارسة ممارسة كرة الطائرة، أو عادية، أو ركوب الدراجة بسرعة خفيفةرفع أشياء  ويمكن أن تتضمن
لا تحسب المشي ضمن هذه الأنشطة. مرة  .أو كنس المنزل، أو غسل الملابس يدويًا، أو غسل السيارة، الطاولة
  في كل مرة.  على الأقل دقائق 01الشدة التي قمت بممارستها لمدة  ةأخرى، فكر فقط في الأنشطة البدنية معتدل
 ، كم يومًا مارست فيه نشاطًا بدنيًا معتدل الشدة؟الماضية ةالأيام السبعخلال  -3
 ____  يوم في الأسبوع   
  5إلى السؤال رقم  مباشرة انتقللا أقوم بأي نشاط بدني معتدل الشدة.                           
 ؟المعتاد، كم من الوقت قضيته في ممارسة نشاط بدني معتدل الشدة في أحد تلك الأيامفي  -4
 ____  ساعة في اليوم   
 ____  دقيقة في اليوم
  لا أدري/ أو غير متأكد.               
لمشي أثناء الآن فكر في الوقت الذي قضيته في المشي خلال الأيام السبع الماضية، ويتضمن ذلك المشي إلى العمل، وا
  . العمل، وفي البيت، وخلال انتقالك من مكان لآخر، أو أي نوع من أنواع المشي بغرض الترويح أو الرياضة
 دقائق على الأقل في كل مرة؟ 01لمدة المشي ، كم يومًا مارست فيه الماضية ةالأيام السبعخلال  -5
 ____  يوم في الأسبوع   
  7إلى السؤال رقم  مباشرة انتقللا أقوم بممارسة المشي إطلاقا.                                
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 في المعتاد، كم من الوقت قضيته في ممارسة المشي في أحد تلك الأيام؟   -6
 ____  ساعة في اليوم   
 ____  دقيقة في اليوم   
  / أو غير متأكد.يلا أدر          
أحسب وقت الجلوس في العمل، وفي المنزل، الماضية. الآن فكر في الوقت الذي قضيته جالسًا خلال الأيام السبعة 
وأثناء العمل على الكمبيوتر،  وفي الدراسة، وفي الترفيه. من الممكن أن يتضمن ذلك وقت الجلوس على المكتب،
  لمشاهدة التلفزيون. ءقاوأثناء زيارتك لصديق، وأثناء القراءة، والجلوس أو الاستل
 ؟أيام الإجازة الأسبوعية ، كم من الوقت قضيته جالسًا في أحد هذه الأيام من غيرالماضية ةالأيام السبعخلال  -7
 ____ ساعة في اليوم 
 ____ دقيقة في اليوم  
  لا أدري/ أو غير متأكد.        
  
  مشاركتكم)نهاية الاستبانة، شكرًا ل( 
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Appendix K 
 
The Summary of Diabetes Self- Care Activities–Arabic (SDSCA-Arabic) Questionnaire 
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The Summary of Diabetes Self- Care Activities Questionnaire - English Version 
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Summary of Diabetes Self-Care Activities Questionnaire 
The questions below ask you about your diabetes self-care activities during the past 7 days. If 
you were sick during the past 7 days, please think back to the last 7 days that you were not 
sick. 
 
Diet 
        Number of Days 
1. How many of the last SEVEN 
DAYS have you followed a 
healthful eating plan? 0 1 2 3   4  5      6         7 
 
2. On average, over the past month, 
how many DAYS PER WEEK have 
you followed your eating 
plan? 0 1 2 3 4 5 6 7 
 
3. On how many of the last SEVEN 
DAYS did you eat five or more 
servings of fruits and 
vegetables? 0 1 2 3 4 5 6 7 
 
4. On how many of the last SEVEN DAYS 
did you eat high-fat foods, such as 
red meat or full-fat dairy 
products? 0 1 2 3 4 5 6 7 
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Physical Activity 
 
5. On how many of the last SEVEN  
 DAYS did you participate in at least  
30 minutes of physical 
activity? 0 1 2 3 4 5 6 7 
 (Total minutes of continuous  
 activity,including walking). 
 
6. On how many of the last SEVEN  
 DAYS did you participate in a  
 specific exercise session (such as 
 swimming, walking, biking) other 
 than what you do around the house 
or as part of your 
work? 0 1 2 3 4 5 6 7 
 
Blood Sugar Testing 
 
7. On how many of the last SEVEN       Number of Days 
 DAYS did you test your blood 
sugar? 0 1 2 3 4 5 6 7 
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8. On how many of the last SEVEN 
 DAYS did you test your blood 
 sugar the number of times 
 recommended by your health- 
care provider? 0 1 2 3 4 5 6 7 
 
Foot Care 
 
9. On how many of the last SEVEN 
DAYS did you check your 
feet? 0 1 2 3 4 5 6 7 
 
10. On how many of the last SEVEN 
 DAYS did you inspect the inside 
of your shoes? 0 1 2 3 4 5 6 7 
 
Smoking 
11. Have you smoked a cigarette, 
 even a puff, in the past SEVEN 
 DAYS?      0 No 1 Yes  
11a.  How many cigarettes did you smoke on an average day? 
Number of cigarettes: ________ 
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Date: …………………………… Participant Code Number: ……………………………… 
HbA1C Data 
The last three measurements (taken over 12 months) if available 
(To be filled by the clinic staff) 
No. Value % Date of the test 
 
 
  
 
 
  
 
 
  
Average 
(To be calculated by the researcher) 
 
 
 
Signature 
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Date: …………………………… Participant Code Number: ……………………………… 
Demographic Data Questionnaire 
 Who is answering the general questions of this questionnaire?  
☐ The Participant     ☐ His Father ☐ His Mother   ☐ Other (Please specify…….)  
 Please answer each question as accurately as possible by circling the correct 
answer or filling in the space provided. 
 
1. What is your age?  __________________ 
 
2.  What is your gender?                      ☐    Female       ☐    Male 
 
 
3. Are you currently a student?             ☐   Yes              ☐   No 
 
 If (Yes), what is your grade? __________________ 
 
4. Parents marital status:                     ☐   Married             ☐   Divorced 
 
5. Do you live with both of them?                    ☐   Yes              ☐   No 
 
 If (No), what is the reason?    ☐Death   ☐Divorced  ☐Father’s travel abroad 
 
6. What is the highest level of education your father has completed? 
☐ Less than high school degree 
☐ High school degree or equivalent 
☐ College degree  
☐ Bachelor degree 
☐ Master degree 
☐ Doctoral degree  
7. What is the highest level of education your mother has completed? 
☐ Less than high school degree 
☐ High school degree or equivalent 
☐ College degree  
☐ Bachelor degree 
☐ Master degree 
☐ Doctoral degree  
8. What is your father employment status? 
☐ Unemployed 
☐ Part-time 
☐ Full-time  
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9.  What is your mother employment status? 
☐ Unemployed 
☐ Part-time 
☐ Full-time 
10. For how long you have been diagnosed with diabetes? 
 
☐1 - ˂2 years  ☐2 - ˂3 years  ☐3 - ˂4 years   ☐4 - ˂5 years   ☐5 years or more  
 
11. Age at diagnosis: __________________ 
 
12. Has any of your family members diagnosed with diabetes?   ☐   Yes        ☐   No 
 If yes, who: 
 
☐ Father ☐ Mother ☐ Brother ☐ Sister  
13. What other medical conditions or diseases do you have other than type 1 
diabetes? 
 
☐ Cystic fibrosis 
☐ Asthma 
☐ Cardiovascular disease 
☐ Kidney diseases  
☐ Autoimmune disease (Please specify…………………………..) 
☐ Eating disorder 
☐ Depression 
☐ Other (Please specify…………………………..) 
☐ Don’t know 
14. What is your height? __________________cm 
 
15. What is your weight? __________________kg 
 
16. What is the mode of insulin delivery?        ☐   Daily insulin injections     ☐   
Insulin pump 
 If on Daily injections, number of injections per day __________________  
 How often is your blood sugar measured per day? __________________   
 
17. Do you have health insurance coverage?                  ☐   Yes              ☐   No 
18. How many times have you been hospitalized due to diabetes last year? ______ 
19. How many episodes of hypoglycemia have you reported last month? ________ 
 
Thank you for completing this personal profile 
IRB NUMBER: HSC-SN-17-0852 
  
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 ……………………………… :rebmuN edoC tnapicitraP …………………………… :etaD
 إستبيان المعلومات الشخصية
 من يجيب على الأسئلة العامة لهذا الاستبيان؟ 
     المشارك              الأب                    الأم          أحد أخر (الرجاء التحديد .............)          
       
الإجابة الصحيحة أو ملء المساحة إختيار يرجى الإجابة على كل سؤال بأكبر قدر ممكن من الدقة عن طريق  
 .المتوفرة
 .................................. سنة العمر .1
 
 أنثى               ذكر                                          الجنس .2
 
 لا               نعم              هل أنت ملتحق بالمدرسة حاليا؟ .3
 
 ), الرجاء تحديد مستى الصف الدراسي ..................................نعمإذا كانت الإجابة ب ( 
 
 مطلقين               متزوجيين                    الحالة الإجتماعية للأبوين: .4
 
 لا               نعم                          كليهما:هل تعيش مع  .5
 
سفر الأب الى      الوفاة      الطلاق      ), فما هو السبب؟   لاإذا كانت الإجابة ب ( 
 الخارج
           
 ما هو  المستوى التعليمي للأب؟ .6
 أقل من الثانوية العامة     
 الثانوية العامة أو ما يعادلها     
 دبلوم كلّية      
 بكالوريوس -درجة جامعية     
 ماجستير  -درجة جامعية     
 دكتوراة -درجة جامعية     
 ما هي طبيعة عمل الأب؟ .7
 بدون عمل                
 وظيفة بدوام جزيء                  
  وظيفة بدوام كامل                 
 471
 
 
 
 ؟مما هو  المستوى التعليمي للأ .8
 أقل من الثانوية العامة                
 الثانوية العامة أو ما يعادلها                
 دبلوم كلّية                 
 بكالوريوس -درجة جامعية                
 ماجستير  -درجة جامعية                
 دكتوراة -درجة جامعية                
 ؟مما هي طبيعة عمل الأ .9
 بدون عمل                
 وظيفة بدوام جزيء                  
  وظيفة بدوام كامل                 
 منذ متى تم تشخيصك بمرض السكري؟ .01
   أقل من سنتينسنة إلى                 
  سنوات 3سنتين إلى أقل من               
 سنوات              4سنوات إلى أقل من  3               
 سنوات  5سنوات إلى أقل من  4                
 سنوات أو أكثر  5               
 .................................. سنة: العمر عند التشخيص .11
 
 لا نعم                 هل هناك أحد من أفراد عائلتك مصاب بالسكري؟      .21
 
 ) على الشخص:√كانت الإجابة ب (نعم), الرجاء الإشارة ب (إذا  
 الأخت                      الأخ                              الأم                         الأب                 
 هل تعاني من أي من الأمراض التالية بالإضافه لمرض السكري؟ .31
 التلّيف الكيسي  
 الربو  
  أمراض القلب و الشرايين              
 571
 
 
 
 أمراض الكلى               
 ( الرجاء التحديد......................................) أمراض المناعة              
 إضطرابات الأكل  
 الأكتئاب  
 التحديد......................................)أمراض  أخرى ( الرجاء               
 لا أعرف  
 .................................. سم  الطول:  .41
 
 .................................. كغمالورن:  .51
 
 ما هي الكيفية التي تتناول بها جرعة الأنسولين؟  .61
 ُحقن الإنسولين اليومية (الحقن تحت الجلد)  
 الأنسولين جهاز مضخة  
ُحقن يوميا ً), كم هو عدد الُحقن الإنسولين اليوميةإذا كانت الإجابة ب ( 
 ..................................
 
 كم مرة يتم قياس نسبة السكر في الدم يومياً؟ .................................. 
 
 لا   نعم                  هل لديك تأمين صحي؟        .71
 
 المستشفى بسبب مرض السكري في العام الماضي؟هي عدد المرات التي كنت قد أدخلت بها  كم  .81
 .....................
 
 
  كم  هي عدد الحالات التي عانيت فيها من نقص السكر في الدم الشهر الماضي؟ .91
 ..................................
 
 شكرًا على إكمال هذا الإستبيان
 
 2580-71-NS-CSH :REBMUN BRI
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Oral Consent Script 
 
I am Yousef Aljawarneh, a Nursing PhD student at University of Texas Health 
Science Center at Houston, USA, and I am currently working on my PhD 
dissertation. I am conducting a research study on “the effects of physical activity, 
health-related quality of life, and adherence on glycemic control in adolescents 
with type 1 diabetes”. The study will help me understand the association between 
these variables and will hopefully provide more information and understanding of 
the factors that facilitate disease management and develop interventions that can 
improve medical and psychosocial outcomes of T1D. 
I would like to ask for your voluntary participation in the study. If you agree to 
participate I will ask you to fill three questionnaires which should take 
approximately 15 minutes. If you do not wish to participate, you may stop at any 
time. All obtained information will be completely anonymous, your name will not 
appear anywhere in the final report, and the information will be used for research 
purposes only. There are no risks associated with your participation. There are 
no direct benefits from participation in the study; however, findings of the study 
may help health care providers to promote better management and care. If you 
would like a copy of this letter for your records, please let me know and I will give 
you a copy. 
 If you have any questions regarding the study, please contact: 
 Yousef Aljawarneh, Mobile: 00962798097033 
 Dr. Mohammad Aljarrah, Mobile: 00962798167489 
 Clinic Nurse, Mobile, 0096227200600 
The study has been reviewed and approved by the Research Ethics Committees 
at KAUH (Jordan) and UTHealth (USA) 
Thank you 
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Screening and Enrollment Log 
Study Title:  IRB Approval:  Researcher Name: 
 
 
 
Title: Site screening and enrollment sheet. 
Purpose: To record screening and enrollment of all participants. 
User: Principal investigator 
Description: the sheet provides a list of all participants who were approached for enrollment and screened for eligibility. The sheet 
should include all participants who were approached, screened, eligible, non-eligible, and consented. The sheet will not contain any 
identifying information. Each sheet contains a total of 10 screenings
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Screening and Enrollment Log 
Participant 
Code 
Number 
Screening 
Date 
 
(DD/MM/YY) 
Eligible  
 
 
(Yes/No) 
Ineligibility 
Reasons 
 
(Select numbers 
from the list below) 
Consent 
Signed 
 
(Yes/No) 
Questionnaires Completed HbA1C 
 
(Yes/No) 
Investigator 
Comments 
HRQoL 
(Yes/No) 
PA 
(Yes/No) 
Adherence 
(Yes/No) 
          
          
          
          
          
          
          
          
          
          
 Eligibility Criteria: 
1 .  Have been diagnosed with Type 1 Diabetes for more than 1 year.  
2 .  12 to 18 years old. 
3 .  In good general health. 
 Ineligibility Reasons 
1 .  Have a medical condition that interferes with physical activity recommendations. 
2 .  Have been diagnosed with Type 1 Diabetes for Less than 1 year. 
3 .  Younger than 12 years old 
IRB NUMBER: HSC-SN-17-0852 
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STUDY PROTOCOL 
Associations between Physical Activity, Health-Related Quality of Life, Regimen 
Adherence, and Glycemic Control in Jordanian Adolescents with Type 1 Diabetes 
Aim: The aim of this study is to examine the associations between physical activity, health-
related quality of life, adherence and glycemic control in Jordanian adolescents with type 
1 diabetes (T1D). 
Time Period: The study will commence between mid of October till the end of December 
2017. 
Setting: All data should be collected from the Pediatrics diabetes clinic at King Abdullah 
University Hospital (KAUH), Irbid, Jordan. 
Approvals: All IRB approvals (KAUH and UTHealth) are enclosed in the operational 
manual within a folder named “IRB Approvals”. 
 The data collector needs to keep a copy of the dual IRB approval all the time when 
collecting data. 
Role of the Principal Investigator: The Principal Investigator (Yousef Aljawarneh) will be 
responsible for all parts of the study including recruitment, screening, data collection, data 
management, data analysis, data interpretation, writing the final results and report, findings 
presentation, and as a communication channel between the study parties. 
 His contacts: 
 Mobile (Jordan): 00962798097033 
 Mobile (United States Of America): 001-682-241-5917 
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 Email: Yousef.m.aljawarneh@uth.tmc.edu 
Data Collection Procedure (Please skip steps if already done): 
 First of all, an orientation session should be scheduled and given to the clinic 
staff. The session should not take more than 15 minutes. The session focuses on 
screening, eligibility, and accessing medical records to obtain the HbA1c values 
for each participant. 
 The study flyer (Arabic version) needs to be posted in the clinic after consulting 
the charge nurse on the appropriate locations. The Arabic version can be found in 
the manual within a folder named “The study flyers”. 
 The data collection should be done within the premises of the designated clinic 
only. Please avoid approaching patients outside the clinic lobby.  
 Before being in the clinic, please make sure to do the followings: 
 Make sufficient copies of the study documents. Make sure to copy from 
the original stamped copies. Copies can be found within the manual. 
 Make one copy of the following documents (The Arabic Version) for each 
participant: the consent form, the demographic data questionnaire, the 
adherence questionnaire, the physical activity questionnaire, the quality of 
life questionnaire, and the HbA1c data sheet. 
 Keep the Enrollment log with you all the time. The enrollment log can be 
found in the manual within a folder named “Questionnaires and 
Documents”. 
 Keep sufficient stationary while in the clinic (pencils, sharper, eraser, 
pens). The stationery can be found in the clinic (please check with the 
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charge nurse) or in the co-advisor’s office; Dr. Mohamed AL-jarrah 
(Mobile: 00962798167489). 
 The clinic staff can only help in the screening and eligibility parts, they 
cannot ask eligible participants to sign the consent form or fill the study 
questionnaires. 
Recruitment: Please follow the steps sequentially 
 The data collector is to be stationed all the time in the clinic on Mondays and 
Wednesdays. 
 When the data collector arrives at the clinic, notify the clinic staff to start 
identifying eligible participants for enrollment. If a participant found to be 
eligible, then approach him/her and ask for any interest in the study if his/her 
parents agree. 
 Explain the study purpose and outcome. 
 Inform him/her that the participation is voluntary. 
 If a participant shows an interest to enroll after reading the flyer, please do the 
screening in the presence of his/her parents. 
 Please do the screening in a private room at the designated clinic while waiting to 
be seen by their physician or after finishing their appointment when they are still 
in the clinic. 
 If he/she does not show any interest in participation, thank the participants for 
their time. 
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 Use the “Enrollment Log” and fill the necessary data as indicated for this and 
each participant. In this case, the “Eligibility column” in the log should be filled 
with “No”. Then select from the list provided the reason for ineligibility. 
 If he/she agreed to participate, thank the participants for their time and for their 
participation in the study. 
 Use the “Enrollment Log” and fill the necessary data as indicated. Give the 
participant a code number. The first approached participant (eligible or not) takes 
number “1” in the series. The second approached participant (eligible or not) 
takes number “2” in the series, and so forth. 
 In this case, the “Eligibility column” in the log should be filled with “Yes”. 
 Obtain the consent form (Arabic version): 
 Fill in the date and participant code number. 
 Type the participant name 
 Type the participant medical record number (MRN). You can obtain it 
from the participant file. 
 Put the researcher name and phone number. 
 Type the short form of the study title (Glycemic control in Jordanian 
adolescents with Type 1 Diabetes). 
 Let the participant and his/her parents read the consent form. 
 Please clarify any query. 
 Put the PI name and Phone number for further questions (Yousef 
Aljawarneh, 00962798167489). 
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 Get the participant’s signature, the first witness, the second witness, and 
the researcher witness. 
 Make a copy of the signed consent and hand it to the clinic nurse in order 
to keep it in the participant’s file. 
 Then ask the participant to complete the following questionnaires: 
 The demographic data questionnaire (Arabic Version). 
 The adherence questionnaire (Arabic version). 
 The physical activity questionnaire (Arabic version). 
 The quality of life questionnaire (Arabic version). 
o For participants aged 13-18 years, please use the recommended 
version for 13-18 years old adolescents. 
o For participants aged 12 years old, please use the recommended 
version for 8-12 years old adolescents. 
o  In case the participant can’t complete the questionnaire and the 
parents are willing to complete it, please use the parents’ proxy 
version. 
 On each questionnaire, put the date and the participant code number. 
 Again, during the distribution of the questionnaire, tell the participant that the 
information will be kept anonymous and participation is completely voluntary. 
 Briefly explain the purpose of each questionnaire. 
 Briefly explain how to respond to each item in each questionnaire. 
 Advise the participant to complete each item in each questionnaire without input 
from others and to select only one answer for each question. 
188 
 
 
 178 
1
81
 
 Remain with the participant in the same room in the presence of his/her parents to 
answer any question or comment. 
 Collect the completed questionnaires when he/she finish. 
 Once finished, check that all items in each questionnaire have been answered. 
 Ask each participant for any further comments and if he/she struggled with any 
item or was difficult to understand. 
 Mark each questionnaire with the participant’s code number, date, and time of 
completion. 
 Thank the participant again. 
 The singed consent form and the completed questionnaires (The demographic 
data questionnaire, The adherence questionnaire, The physical activity 
questionnaire, The quality of life questionnaire) will be attached all together in 
one file for each participant and labeled with the participant code number. 
 At the end of each day, meet with the PI and with the co-advisor for debriefing. 
 Place the collected files in the co-advisor’s office in a folder labeled “Glycemic 
Control-Completed” with the master list of subject IDs in a locked file cabinet. 
Data Management  
 Data entry is the responsibility of the PI. 
 Two MASTER Datasets are created in SPSS: one for the PI and one for the co-
advisor for double checking the entered data (data verification). 
 Both versions are located on two separate laptops (one with the PI and one in the 
co-advisor office).  
 These datasets are named as “Glycemic-Control PI” and “Glycemic-Control CO.  
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 Double-check accuracy of data entry against the original participants’ 
questionnaires with the co-advisor. 
Data Analysis 
 Data analysis is the responsibility of the PI. 
 Please use the following scoring protocol for each questionnaire as a reference. 
All scoring protocols are enclosed in the study manual within a folder named 
“Scoring Protocols”: 
 Quality of Life Questionnaire: Scoring PedsQL 
 Adherence Questionnaire: Scoring Adherence 
 Physical Activity Questionnaire: IPAQ Scoring 
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